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Dopamine is an important neurotransmitter involved in a variety of physiological functionality 
such as motor control, cognition, sexual arousal and reward.  Furthermore, dysfunction in the 
dopaminergic system can lead a number of devastating neurological disorders including Parkinson’s 
disease, schizophrenia, Alzheimer’s, and substance abuse.  Therefore, understanding the real-time 
mechanisms of dopamine signaling is of utmost importance.   
Real-time analysis of in vivo dopamine poses an interesting analytical challenge.  Dopamine is 
released into the extracellular space deep below the cortical surface in nanomolar to micromolar 
concentrations on a sub-second timeframe.  Because of these conditions, effective dopamine 
quantification requires a small selective detector that exhibits high temporal resolution and a low limit 
of detection.  Fast scan cyclic voltammetry at carbon fiber microelectrodes has proven to be ideal for 
this task.  The work detailed in this dissertation pairs in vivo voltammetry with electrical stimulation of 
dopaminergic axonal projections to controllably study dopamine kinetics. 
Previously our laboratory discovered the existence of two discrete dopamine domains in the rat 
dorsal striatum that exhibit unique dopamine kinetic responses to electrical stimulation.  This 
dissertation is built on the foundation of that work.  First, we discovered that the effect of a competitive 
inhibitor of the dopamine transporter is domain dependent.  The kinetics of these domain dependent 
effects allowed us to predict that dopamine signaling in the extracellular space is subjected to restricted 
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diffusion.  We continued on to show that restricted diffusion prevents cross-talk between domains, thus 
maintaining a strict physical segregation between domains.  Further work resulted in the discovery of 
five discrete dopamine domains.  These domains exhibit differing extents of regulation, resulting in 
unique kinetic responses to electrical stimulation.  Finally, we discovered the existence of long-term 
dopamine signaling.  Following electrically stimulated dopamine release, free dopamine in the 
extracellular space is not completely cleared as previously believed.  Instead, the free dopamine 
establishes a new steady state elevated baseline concentration.  These discoveries provide new insight 
into the complex mechanisms that regulate dopamine signaling, and have the potential to explain the 
multiple functionalities of the dopaminergic system. 
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1.0:  INTRODUCTION 
 
 
 
1.1:  HISTORY AND ANATOMY OF DOPAMINE TRANSMISSION 
 
 
Dopamine (DA) is a catecholamine neurotransmitter responsible for maintaining many vital life 
functions in species ranging from the simple fruit fly to humans.  The molecule was first synthesized in 
1910 by Carl Mannich and Willy Jacobsohn in Germany (Mannich and Jacobsohn, 1910) and by George 
Barger and Arthur James Ewins in England (Barger and Ewins, 1910).  It has been studied extensively 
since its physiological relevance as a neurotransmitter was uncovered by Nobel Prize laureate Arvid 
Carlsson and coworkers in 1958 (Carlsson et al., 1958).  In humans, as well as in the rat model, DA 
signaling occurs along nine distinct pathways (Winn, 2001) and control a wide variety of functioning such 
as motor control, reward, reinforcement, cognition and addiction (Horn et al., 1979).  This dissertation 
focuses on transmission along the nigrostriatal dopamine pathway, which maintains reward, addiction, 
and motor functioning (Horn et al., 1979).  In the nigrostriatal pathway the cell bodies originate within 
the substantia nigra portion of the midbrain, axons follow the ventrally located medial forebrain bundle 
and the terminals and signaling varicosities are located throughout the dorsal striatum (Horn et al., 
1979, Winn, 2001).  Dysfunction of DA signaling has been found to be responsible for numerous 
disorders such as Parkinson disease, Schizophrenia, Alzheimer’s disease, ADHD and substance abuse 
(Phillips et al., 2003, Pappata et al., 2008, Salahpour et al., 2008, de la Fuente-Fernandez et al., 2011, 
Kim et al., 2011)  All disorders that require treatment with drugs that alter DA signaling such as L-3,4-
dihydroxyphenylalanine (L-DOPA), methylphenidate (Ritalin) and haloperidol (Haldol) (Gottwald and 
Aminoff, 2011, Schlochtermeier et al., 2011, Valenti et al., 2011). 
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DA is released at the 300 nm long by 15 nm wide synaptic junction (Garris et al., 1994) between 
DAergic neuron terminals and neighboring γ-aminobutyric acid (GABA) cells (Smith and Bolam, 1990).  In 
the striatum, these synaptic junctions are located at a density of 0.05/μm3 or one every 3.5 μm (Doucet 
et al., 1986, Rice and Cragg, 2008).   Inside the DAergic neuron, DA is synthesized first by the conversion 
of L-tyrosine to L-DOPA by tyrosine hydroxylase, and then from L-DOPA into DA by DOPA decarboxylase 
(Elsworth and Roth, 1997).  Once synthesized, DA is packaged into 50 nm diameter (Greengard et al., 
1993) synaptic vesicles by the SLC18 family 2H+/DA antiporter protein, vesicular monoamine transporter 
2 (VMAT-2) (Eiden et al., 2004, Guillot and Miller, 2009) and stored at concentrations of around 0.1 M 
(Elsworth and Roth, 1997).  Maintenance of a high proton concentration within the synaptic vesicle is 
important in order to facilitate DA influx and to maintain the acidic environment needed to ensure that 
DA is not oxidized (Guillot and Miller, 2009).  Loaded vesicles congregate near the synaptic junction and 
await release (Greengard et al., 1993).  When the cell triggers release, rapid depolarization along the 
axonal membrane, termed an action potential, propagates from the cell body to the terminal region at a 
rate of approximately 50 m/sec (Wightman et al., 1988b).   Once the action potential reaches the 
voltage mediated Ca2+ channels located at the neuron terminal, Ca2+ is allowed to enter the cell 
(Ceccarelli and Hurlbut, 1980), triggering intracellular pathways that cause DA vesicles to release their 
contents into the extracellular space via exocytotic vesicle fusion (del Castillo and Katz, 1956, Wightman 
et al., 1988b).  DA floods into the synaptic junction and rapidly diffuses out into the extracellular space 
where it comes in contact with a number of regulatory and uptake proteins (Garris et al., 1994, Michael 
and Wightman, 1999). 
Autoinhibitory regulation of DA release in the striatum, along with GABA signaling, occurs 
through DA binding to g-protein coupled receptors.  These receptors, classified into D1 and D2 receptor 
families, consist of seven transmembrane domains and readily bind extracellular DA (Palermo-Neto, 
1997, Missale et al., 1998).  D2 type receptors, IC50 for DA of 2.5 μM (Onali et al., 1985), are found on 
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both the pre and post synaptic membrane as well as on the DA neuron cell bodies in the substantia 
nigra.  DA binding to D2 receptors corresponds to intracellular Gi signaling and results in increased 
production of intracellular cyclic adenosine monophosphate (cAMP) (Onali et al., 1985, Palermo-Neto, 
1997, Missale et al., 1998).  D1 type receptors are found only on the post synaptic membrane and result 
in intracellular Gs signaling upon DA activation that leads to a decreased production of cAMP (Onali et 
al., 1985, Missale et al., 1998).  DA binding to presynaptic D2 receptors also serves as an autoinhibitory 
mechanism by decreasing vesicular release.  This is caused by a g-protein coupled activation of outward 
K+ channels, leading to a hyperpolarization that inhibits action potentials (Martel et al., 2011).   
In addition to extracellular DA encountering D1 and D2 receptors, free DA is taken back into the 
cell by means of the DA transporter protein (DAT) (Benoit-Marand et al., 2000, Wu et al., 2001a, Torres, 
2006, Salahpour et al., 2008).  DAT is a typical SLC6 family 2Na+/Cl-/DA symporter protein that consists of 
twelve transmembrane domains, forming a pore within (Fon et al., 1997, Torres, 2006, Torres and 
Amara, 2007).  After uptake by DAT, DA is either repackaged into vesicles for rerelease (Guillot and 
Miller, 2009) or degraded by monoamine oxidase (MAO) found on the outer membrane of mitochondria 
(Waldmeier et al., 1976, Okada et al., 2011).  In addition to uptake, DAT has been shown to be 
responsible for DA release.  Numerous studies have shown that after treatment with amphetamine, 
spontaneous nonvesicular release occurs via the DAT (Sulzer et al., 1993, Giros et al., 1996, Kahlig et al., 
2005).  In addition, recent work by our laboratory has suggested that the local basal extracellular 
concentration of DA in the striatum is maintained by DAT mediated release (Borland and Michael, 2004, 
Moquin and Michael, 2009, Wang et al., 2010). 
 
 
1.2:  OXIDATION AND REDUCTION OF DOPAMINE 
 
 
DA readily oxidizes to its dopamine o-quinone form through a two electron, two proton transfer 
reaction upon application of a potential that is more positive than DA’s E˚ (Hawley et al., 1967, Tse et al., 
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1976, Laviron, 1984, Deakin and Wightman, 1986, Michael and Borland, 2007).  Subsequently, upon 
application of a potential more negative than DA’s E˚, the dopamine o-quinone is reduced back to 
dopamine.  This reduction also requires the transfer of two electrons and two protons.  The electron 
transfer associated with these reactions produce a measurable current that can be quantified at the 
carbon fiber working electrode (Bard and Faulkner, 2001).  The standard redox potential for DA was 
found to be 0.11 V versus the saturated calomel reference electrode (Bath et al., 2000), which converts 
to 0.10 V versus the Ag/AgCl reference electrode that is used in this study.  
If the dopamine o-quinone is not reduced back to dopamine, it can undergo a number of cross 
reactions which could alter the magnitude of the detected current.  Dopamine o-quinone readily serves 
as an oxidizing agent for ascorbic acid at physiological conditions.  In this reaction, dopamine o-quinone 
oxidizes ascorbic acid by stripping it of its two electrons and two protons, thus reducing the dopamine o-
quinone back to dopamine (Tse et al., 1976, Michael and Borland, 2007).  If this reaction is allowed to 
occur, the amount of dopamine detected at the carbon fiber would be higher than expected due to a 
recycling of previously oxidized DA back to the carbon fiber.  Also, an oxidation peak for ascorbic acid 
would be present that could skew the reading.  Dopamine o-quinone can also undergo a cyclization 
reaction to an indole, which undergoes further oxidation to an aminochrome (Tse et al., 1976).  
Although this cyclization reaction is very slow under physiological conditions, the reaction is irreversible, 
and thus would cause an unexpected depletion of dopamine if the dopamine o-quinone is not reduced 
back to DA in a timely manner. 
 
1.3:  FAST SCAN CYCLIC VOLTAMMETRY 
Due to the electrochemical nature of catecholamines, such as DA, cyclic voltammetry was first used by 
Ralph Adams’ lab for the detection of neurotransmitters in vitro in 1967 (Hawley et al., 1967).  Six years 
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later, Kissinger, Hart and Adams were the first to use cyclic voltammetry to detect a change in 
catecholamine concentration in vivo (Kissinger et al., 1973).  Cyclic voltammetry is a method used to 
detect the presence of electroactive species in an environment without altering the chemical system 
(Bard and Faulkner, 2001).  The method makes use of potential dependent electrochemical reactions 
following the form described in Equation 1.1, where Ox is the oxidized species, ne- is the number of 
electrons transferred, and Red is the reduced species. 
Equation 1.1    Ox + ne- ↔ Red                
When electrons are transferred in such a reaction, a measurable current is produced that is directly 
proportional the concentration of the electroactive species.  This proportionality is governed by the 
Randles-Sevcik equation, shown in Equation 1.2 (Michael and Wightman, 1999, Bard and Faulkner, 
2001). 
Equation 1.2                     
                                              
In the Equation 1.2, ipeak denotes the peak current, 2.69 x 10
5
 is a constant, n is the number of electrons 
being transferred, A is the area of the electrode, D is the diffusion coefficient for the species of interest, 
C
*
 is the concentration of the species of interest and v is the scan rate of the potential waveform.  In a 
given experiment where the electrode, species of interest, and environment are unchanged, the 
constant, n, A, D, and v all remain constant and can be combined together to form the calibration 
factor, α.  Equation 1.2 thereby reduces down to Equation 1.3, where current relates to concentration 
by a simple calibration of α. 
Equation 1.3                                                        
                                                            
Using cyclic voltammetry, electrochemical reactions are driven by altering the potential, relative 
to a reference electrode, applied to the system via a controllably ramped waveform.  The potential 
waveform begins at a designated resting potential, sweeps in a given direction until reaching a desired 
switching potential and then reverses to sweep in the opposite direction.  This process is repeated until 
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the user defined waveform is complete and the potential returns to its resting baseline to await the next 
scan.  When the waveform reaches potential values specific for the oxidation or reduction of the 
electroactive species, the electron transfer reaction will occur and a measurable current can be detected 
at the working electrode (Bard and Faulkner, 2001).  The potential waveform can be applied at as high 
or low of a frequency as the user prefers.  In this work, the waveform was applied at the relatively high 
frequency of 10 Hz to ensure sufficient temporal resolution necessary to detect changes in DA on the 
time scale of neuronal firing.   
When the induced current is plotted versus the potential of the applied waveform, the image 
produced is referred to as a cyclic voltammogram.  Because the potentials of oxidation and reduction for 
a given molecule remain unchanged as long as the run conditions are unaltered (Bard and Faulkner, 
2001), this plot serves as a distinguishing fingerprint used to determine the source of the current.  By 
qualitatively comparing the peak locations of a cyclic voltammogram to a database of standard 
compounds possibly located in the reaction matrix, a potential source match can be found.  It is 
important to note that if there are two or more compounds possibly found in a given matrix that 
produce identical cyclic voltammograms, it is impossible to determine which is the source of the signal 
without further testing. 
In typical cyclic voltammetry experiments, where waveforms are swept at the relatively slow 
rate of 0.1 V/sec to 1 V/sec, the oxidation and reduction peaks in the cyclic voltammogram are sharp 
and separated by 59 mV/n, where n is the number of electrons transferred (Bard and Faulkner, 2001).  
These peaks are found to broaden and migrate away from each other when reactions are more complex 
and when the scan rate of the potential waveform is increased (Michael and Wightman, 1999, Bath et 
al., 2000, Bard and Faulkner, 2001).  Although the transfer of more than one electron should narrow the 
distance between peaks (59 mV/n), when more than one electron and proton are transferred, there is a 
possibility of the reaction following different electron and proton transfer pathways for the oxidation 
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and reduction reactions.  This would result in the processes exhibiting different rates and thus shifting 
peak locations.  Reactions consisting of a two electron and two proton transfer, such as DA, are modeled 
using the nine membered box scheme (Laviron, 1984, Deakin and Wightman, 1986).  When the scan 
rates are increased to the range typical of fast scan cyclic voltammetry (FSCV) (100 V/sec – 1000 V/sec), 
peaks are shifted and broadened because the electron transfer kinetics between the analyte and the 
electrode surface are not instantaneous.  By the time the current is detected at the carbon fiber, the 
potential waveform has swept to another value and shifted the peak (Bath et al., 2000).  This increase in 
scan rate is a necessary feature for in vivo DA detection because of the aforementioned cross reactions 
that the oxidized dopamine o-quinone can undergo if not immediate reduced.   
 
1.4:  FSCV AT CARBON FIBER MICROELECTRODES 
Due to findings indicating that damage associated with the implantation of large probes in brain tissue 
causes a loss of neuronal functioning (Borland et al., 2005, Jaquins-Gerstl and Michael, 2009), it is 
imperative that a small detector be used for implantation.  In 1978 Francois Gonon and colleagues first 
used a carbon fiber microelectrode to detect DA in vivo (Gonon et al., 1978).  These cylindrical probes 
are typically 7 μm in diameter and can be cut to whatever length desired.  The use of these small 
electrodes allows for implantation with relatively little damage to the surrounding tissue (Peters et al., 
2004, Jaquins-Gerstl and Michael, 2009).  When the potential applied to the carbon fiber microelectrode 
is rapidly changed, such as is required for the in vivo detection of DA by FSCV, a large non-faradic current 
is observed.  This is a result of ions from the brain fluid orienting along the electrode surface to balance 
the potential difference caused by the rapidly changing potential waveform (Michael and Wightman, 
1999, Bath et al., 2000, Bard and Faulkner, 2001).  This capacitive charge build up between the electrode 
surface and the surrounding fluid is referred to as the charging current and scales according to Equation 
1.4 (Wipf et al., 1988, Michael and Wightman, 1999, Bath et al., 2000, Bard and Faulkner, 2001).   
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 Equation 1.4                                                                                                    
In Equation 1.4 icap is the capacitive charging current, A is the area of the electrode, C is the capacitance 
and v is the scan rate.  It can be seen that both the faradaic peak current, ipeak shown in Equation 1.2 and 
the capacitive charging current, icap displayed in Equation 1.4, are dependent on scan rate, v.  ipeak is 
proportional to    , while icap is related to v.  This relationship indicates that if scan rates become too 
large, the charging current will far outweigh the peak current, thus putting a functional limit on the 
experimental scan rate used.  Due to the presence of this charging current during all measurements, the 
detection of an electroactive species by FSCV requires a background subtraction of the current 
generated prior to the introduction of the analyte.  This need for background subtraction therefore 
makes cyclic voltammetry a differential detection method and prevents the measurement of resting 
analyte levels.   
 As is typical with electrochemical detection in static environments, the oxidation of DA and 
subsequent reduction of dopamine o-quinone are dependent on diffusional mass transport of the 
reactive species to the electrode surface.  As the layer of DA on the surface of the working electrode is 
oxidized to dopamine o-quinone, a flux of fresh DA is brought to the electrode surface to replace the 
newly produced dopamine o-quinone.  The opposite is also observed for the reduction of dopamine o-
quinone at the electrode surface.  This motion is governed by Fick’s Law (Bard and Faulkner, 2001) and 
allows for constant sampling of the extracellular environment.  In addition to diffusional mass transport, 
DA and dopamine o-quinone also adsorb to the surface of the carbon fiber working electrode (DuVall 
and McCreery, 1999, Bath et al., 2000, DuVall and McCreery, 2000) through a process involving DA’s 
positively charged amine moiety (Bath et al., 2000).  DA is modeled to first adsorb to the carbon fiber 
surface, then undergo oxidation to dopamine o-quinone while adsorbed and then release the dopamine 
o-quinone into solution, with the adsorption and desorption processes viewed as first order kinetic 
processes (Bath et al., 2000, DuVall and McCreery, 2000).  This adsorption was found to be a necessary 
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part of the electrochemical detection of DA by carbon fiber working electrodes.  When adsorption to the 
carbon fiber was inhibited, the electrochemically detected DA signal disappeared (DuVall and McCreery, 
1999).   
 
1.5:  QUANTIFICATION AND SITE SPECIFICITY OF EVOKED DA OVERFLOW 
In 1988 Mark Wightman introduced the theory that the change in concentration of extracellular DA over 
time, termed evoked DA overflow,  is a quantifiable balance between Ca2+ dependent vesicular release 
and DAT mediated uptake (Wightman et al., 1988a, Michael and Wightman, 1999, Michael et al., 2005).  
His proposed mathematical model makes the assumptions that the concentration of DA released per 
pulse, [DA]p, is constant and independent of stimulation frequency, that DAT mediated uptake is the 
only method of DA clearance and that DAT uptake is defined by Michaelis-Menton kinetics.  The model 
for evoked overflow described in Equation 1.5 describes the change in concentration of extracellular DA 
([DA]ex) over a given time. 
Equation 1.5                          
1
][*
][
][
max


ex
m
DA
Kp
ex VDAf
dt
DAd
        
In Equation 1.5, f is the frequency of stimulation pulse, [DA]p is the concentration of DA released per 
pulse, Vmax is the maximum rate of DA uptake via DAT and Km is the binding constant.  According to this 
model, when vesicular release is halted, the equation reduces down to solely DAT mediated uptake 
kinetics, shown in Equation 1.6. 
Equation 1.6                                     
1
][
][
max



ex
m
DA
K
ex V
dt
DAd
                                     
Wightman asserts that his model adequately fits many of the previously published DA evoked overflow 
curves found in the striatum (Wightman et al., 1988a).  In future studies, locations within the striatum 
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that produced kinetics consistent with the predictions of the Wightman model came to be termed “hot 
spots” (Venton et al., 2003), while other locations, with kinetics deviating from the Wightman model, 
were labeled as “non-DAergic” (Venton et al., 2003) sites consisting of artifacts of diffusion and not 
studied (May and Wightman, 1989b, Garris et al., 1994, Peters and Michael, 2000, Venton et al., 2003).   
The previously modeled “hot spot” type sites showed a rapid increase in evoked overflow upon 
the start of stimulated release, fast onset of D2 autoinhibition upon continued stimulation and fast 
clearance (Moquin and Michael, 2009, Moquin and Michael, 2011).  This produced a characteristic 
concave down shape for the evoked overflow curve where the amount of DA evoked during the first 100 
ms of stimulation is greater than that evoked during the following 100 ms of stimulation.  Domains 
typical of this kinetic profile were deemed “fast sites”.  A typical fast site is shown in Figure 1.1a.  In 
2009, our lab discovered that the “non-DAergic” sites that were previously discarded as an artifact of 
diffusion were reproducible and subject to pharmacological manipulation.  These sites show slow initial 
evoked overflow signal, with no detectable change in DA present during the initial 200 ms of 
stimulation, an increase in signal upon further stimulation and slower clearance (Moquin and Michael, 
2009, Moquin and Michael, 2011).  The evoked overflow signal increases in a concave up manner, where 
the previous 100 ms of stimulation evoked less DA than that produced by the following 100 ms of 
stimulation.  Although these domains exhibit the leading shoulder typical of a diffusional curve, the 
evoked response was found to clear immediately upon the end of stimulation, contrary to a diffusional 
mechanism.  Domains typical of this kinetic profile were named “slow sites”.  A typical slow site is shown 
in Figure 1.1b. 
In addition to distinguishing between fast and slow sites, our lab proposed that the kinetic 
profile of DAergic neurons are under control of the local basal DA concentration of 2 µM DA (Borland 
and Michael, 2004, Wang et al., 2010).  Fast sites are believed to exist in the presence of a lower 
extracellular basal concentration of DA and subsequently show immediate release under no initial D2  
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Figure 1.1:  Fast and slow domain responses.   
DA release in the dorsal striatum is heterogeneous.  The response depicted in (a) is termed a “fast site” 
and exhibits kinetics predicted by the Wightman Model of DA transmission.  Fast sites show an 
immediate increase in DA upon the start of stimulation (circle) and fall immediately upon the end of 
stimulation (triangle).  Furthermore, the amount of DA released during the first 100 ms of stimulation 
(from the circle to the diamond) is greater than the amount of DA released during the second 100 ms of 
stimulation (from the diamond to the triangle), indicating an onset of autoinhibition.  The response 
shown in (b) is that of a “slow site”.  Upon the start of stimulation (circle) release is slow (1), but then 
accelerates as stimulation continues (2) and falls immediately upon the end of stimulation (triangle) (3).  
Image courtesy of (Moquin and Michael, 2009). 
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autoinhibitory control, illustrated in Figure 1.2a.  On the other hand, slow sites are modeled as existing 
in a high basal concentration of DA, which establishes a D2 autoinhibitory tone that inhibits release 
upon the start of stimulation, modeled in Figure 1.2b.  This model was supported by pharmacological 
manipulation of the D2 autoreceptor (Moquin and Michael, 2009, Wang et al., 2010, Moquin and 
Michael, 2011).  Treatment of a fast site with a D2 agonist, such as quinpirole, produces kinetics typical 
of a slow site (Figure 1.3a), whereas administration of a D2 antagonist, such as raclopride, to a slow site 
produces fast type kinetics (Figure 1.3b).  This showed that the extent of D2 mediated autoinhibition can 
determine site kinetics.  Furthermore, in conjunction with findings from other studies, it was shown that 
control over this fast and slow site specific local basal DA concentration difference is maintained by DAT 
mediated release (Borland and Michael, 2004, Moquin and Michael, 2009, Wang et al., 2010).  
This dissertation details numerous discoveries that further the understanding of fast and 
slow DA kinetic domains and of DA transmission in the brain as a whole.  The enclosed research 
discusses the domain dependent effect of the competitive DAT inhibitor, nomifensine, the 
important role of restricted DA diffusion in the extracellular space in maintaining fast and slow 
domains, the existence of four additional sub-domains of the fast domain and how highly 
selective and sensitive detection allows for the discovery of long term DA signaling in vivo.  
These discoveries have already become the intellectual basis of new scientific research and 
have the potential to uncover the unknown mechanisms underlying the multiple physiological 
functionalities and pathologies of the DA system.  
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Figure 1.2:  Schematic representation of fast and slow domains. 
Domain dependent DA transmission is under the control D2 autoinhibition.  (a) In fast sites, local basal 
extracellular DA concentrations are low enough that the D2 autoreceptor is unbound.  Due to this lack of 
initial autoinhibition, vesicular release occurs immediately upon the presence of an action potential. (b) 
In slow sites, the local basal extracellular DA concentration is high enough (around 2 µM) to activate the 
D2 autoreceptor.  Due to this autoinhibitory tone, immediate vesicular fusion does not occur upon the 
introduction of an action potential.  
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Figure 1.3:  D2 dependency of fast and slow domains. 
Domain dependent DA transmission is altered by pharmacological manipulation of D2 activity.  (a) 
Treatment of a fast site with the D2 agonist, quinpirole, triggered the site to exhibit kinetics typical of a 
slow domain.  (b) Treatment of a slow site with the D2 antagonist, raclopride, triggered the site to 
exhibit fast type kinetics.  Altered images courtesy of (Wang et al., 2010). 
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2.0:  DOMAIN DEPENDENT EFFECTS OF DAT INHIBITION IN THE RAT DORSAL STRIATUM 
Adapted with revisions from Taylor et al. 2012.  Reproduced with permission. 
 
2.1:  INTRODUCTION 
Dopamine (DA) is a neurotransmitter that participates in multiple aspects of normal brain function 
(Roitman et al., 2004, Obeso et al., 2008) and a variety of brain disorders (Salahpour et al., 2008, de la 
Fuente-Fernandez et al., 2011, Kim et al., 2011).  Consequently, drugs that act on DA have wide-ranging 
uses, some therapeutic (Gottwald and Aminoff, 2011, Schlochtermeier et al., 2011) and some illicit 
(Phillips et al., 2003, Hollander and Carelli, 2007, Ramsson et al., 2011).  Understanding the actions of 
such drugs, including their impact on extracellular DA concentrations, is highly significant.  Drugs such as 
cocaine, methylphenidate and nomifensine, which inhibit DA uptake (Jones et al., 1995b, Jones et al., 
1998, Makos et al., 2010), are psychostimulants (Hunt et al., 1974, Nakachi et al., 1995, Garris et al., 
2003) and have significant abuse potential (Spyraki and Fibiger, 1981, Phillips et al., 2003).   
In the dorsal striatum of the rat, the DA terminal field exhibits domains of distinct fast and slow 
kinetics of DA release and clearance (Moquin and Michael, 2009, Wang et al., 2010, Moquin and 
Michael, 2011).  We have thus far demonstrated that two drugs, raclopride and quinpirole, have 
domain-dependent actions on DA (Moquin and Michael, 2009, Wang et al., 2010).  The activity of the DA 
transporter (DAT) (Gulley and Zahniser, 2003, Torres, 2006, Schmitt and Reith, 2010) appears to be 
domain-dependent as well, as we found the rate of extracellular DA clearance to be significantly faster 
in the fast compared to the slow domains (Moquin and Michael, 2011).  And, DAT reversal contributes 
to a DA autoinhibitory tone in the slow domains (Moquin and Michael, 2009, Wang et al., 2010), which 
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is surprising considering that DAT reversal is thought to require amphetamine-like drugs (Sulzer et al., 
1993, Sulzer et al., 1995).  The objective of the present study, therefore, was to test the hypothesis that 
the actions of nomifensine, a competitive DAT inhibitor (Hunt et al., 1974), might also be domain-
dependent.   
 
2.2:  MATERIALS AND METHODS 
2.2.1:  Carbon fiber electrodes 
Borosilicate capillaries (0.4 mm ID, 0.6 mm OD, A-M systems Inc., Sequim, WA, USA), each containing a 
single carbon fiber (7-μm diameter, T650, Cytec Carbon Fibers LLC., Piedmont, SC,USA), were pulled to a 
fine tip using a vertical puller (Narishige, Los Angeles, CA, USA).  The tip was sealed with epoxy (Spurr 
Epoxy, Polysciences Inc., Warrington, PA, USA), the exposed fiber was trimmed to a length of 200 μm, 
and a mercury drop was placed in the barrel for electrical contact to a hookup wire (Nichrome, 
Goodfellow, Oakdale, PA, USA). 
2.2.2:  Fast-scan cyclic voltammetry 
Voltammetry was performed with an EI 400 (Ensman Instruments, Bloomington, IN) controlled by ‘CV 
Tar Heels v4.3’ software (courtesy of Dr. Michael Heien, University of Arizona, Tucson, AZ, USA).  The 
reference electrode was Ag/AgCl.  The waveform started at the rest potential (0 V vs. Ag/AgCl), ramped 
linearly (400 V/s) to +1.0 V, then to -0.5 V, and then to 0 V.  Scans were repeated at 10 Hz.  DA oxidation 
currents were recorded between 0.5 and 0.7 V on the initial ramp.  DA was identified by inspection of 
background-subtracted voltammograms.  
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2.2.3:  Electrode preparation and calibration 
Electrodes were pretreated and calibrated in artificial cerebrospinal fluid (145 mM Na+, 1.2 mM Ca2+, 2.7 
mM K+, 1.0 mM Mg2+, 152 mM Cl-, and 2.0 mM phosphate, pH 7.4).  The pretreatment was a triangular 
potential waveform (0-2 V, 200 V/s for 3 s) (Feng et al., 1987, Wang et al., 2010).  Pre- and post-
calibration were performed in a flow cell with freshly prepared, nitrogen-purged dopamine HCl (Sigma 
Aldrich, St. Louis, MO, USA) standard solutions.  In vivo DA concentrations were determined by post 
calibration results. 
2.2.4:  Drugs 
Isoflurane (Aerrane, Baxter Healthcare, Deerfield, IL, USA) was delivered by means of a calibrated gas 
anesthesia machine (IsoTec, Harvard Apparatus, Holliston, MA, USA).  Nomifensine maleate was used as 
received (Sigma Aldrich, St. Louis, MO, USA) and dissolved in phosphate buffered saline (155mM Na+, 
155mM Cl-, 100mM phosphate, pH 7.4)  
2.2.5:  Animals 
All procedures involving animals (male Sprague-Dawley rats, 250-350 g, Hilltop, Scottsdale, PA, USA) 
were approved by the University of Pittsburgh’s Institutional Animal Care and Use Committee.  Rats 
were intubated and anesthetized with isoflurane (2.5% by volume) and placed in a stereotaxic frame 
with the incisor bar raised to 5 mm above the interaural line(Pellegrino et al., 1979).  Internal body 
temperature was monitored and maintained at 37˚C by use of a heating blanket (Harvard Apparatus, 
Holliston, MA, USA).  Holes were drilled through the skull for the reference, stimulating, and working 
electrodes.  Electrical contact between brain tissue and a reference electrode was via a salt bridge.  The 
stimulating electrode (bipolar stainless steel, MS303/a; Plastics One, Roanoke, VA, USA) was aimed at 
the medial forebrain bundle (MFB, 2.2 mm posterior to bregma, 1.6 mm lateral from bregma, and 7-8.5 
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mm below the cortical surface: the final vertical placement was adjusted to evoke DA release in the 
ipsilateral striatum) (Ewing et al., 1983, Kuhr et al., 1984, Stamford et al., 1988).  The carbon fiber 
electrode was implanted into the dorsal striatum (2.5 mm anterior to bregma, 2.5 mm lateral from 
bregma and 5 mm below the cortical surface: the final vertical placement was optimized as explained in 
the Results Section). Confirmation of electrode placements by histology was not considered necessary in 
this study because the dorsal striatum is a large brain structure in the rat and easily targeted.  The 
optically isolated stimulus waveform (Neurolog 800, Digitimer, Letchworth Garden City, U.K.) was a 
biphasic, constant-current, square wave (4 ms per pulse, 240 μA pulse height, and 60Hz frequency).  The 
stimulus duration was 200 ms or 3 s (see Results section for detail on the stimulus duration).   
Each rat received a series of pre-nomifensine stimuli, a single dose of nomifensine (20 mg/kg i.p) 
and a final post-nomifensine stimulus: the final stimulus was performed 30 min after nomifensine 
administration.  The same electrodes, recording location, stimulating locations, stimulus parameters, 
etc., were used during the pre- and post-nomifensine responses.  During this study, we compared pre- 
and post-nomifensine responses in the same group of animals to assure the effect of the drug was 
established at the same stimulating and recording electrodes.  This approach, i.e. comparing pre- and 
post-drug responses is widely used (Wu et al., 2002, Venton et al., 2006, Moquin and Michael, 2009, 
Wang et al., 2010) and is based on a number of early voltammetric studies that established the high 
stability of electrically evoked DA responses (e.g. (Ewing et al., 1983, Millar et al., 1985, Michael et al., 
1987a, b, Suaud-Chagny et al., 1995, Kulagina et al., 2001, Benoit-Marand et al., 2011) . 
According to Davidson et al. (2000), prolonged exposure to nomifensine poisons carbon fiber 
electrodes.  During this study, electrodes were exposed for only 30 min to a single dose of nomifensine.  
The poisoning effects noted by Davidson et al. were not observed during this study.   
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2.2.6:  Data analysis 
The initial rate of evoked DA overflow was determined from the slope of the evoked responses during 
the first 200 ms of each electrical stimulus.  The initial linear DA clearance rate was measured from the 
slope of the descending phase of the response after the end of the stimulus: linear segments of this 
phase were defined by at least three data points with an r2>0.96.  Overshoot time was the length of time 
needed after the end of the stimulus for the evoked response to reach its maximum amplitude.  The 
overshoot concentration was the amount by which the DA concentration continued to increase after the 
end of the stimulus.  Statistical analyses were by t-test and two-way ANOVA with a repeated measures 
design (SPSS software). 
2.2.7:  Electron microscopy 
Electron microscopy of carbon fiber probe tracks, including tissue processing and tracing the electrode 
track, was performed as previously described (Peters et al., 2004). 
 
2.3:  RESULTS 
2.3.1:  Domain-dependent dynamics of evoked DA release and clearance 
Evoked DA responses in the rat dorsal striatum are domain-dependent (Moquin and Michael, 2009, 
Wang et al., 2010, Moquin and Michael, 2011).  Responses in fast domains (Figure 2.1 solid line) exhibit 
a) a rapid onset when the stimulus starts (DA is readily detected on the first FSCV measurement 100 ms 
after the stimulus begins), b) short term depression (less increase in DA during the 2nd 100 ms of the 
stimulus than during the first 100 ms), c) no delay in DA clearance after the stimulus ends (no 
“overshoot”), and d) rapid DA clearance.  Responses in slow domains (Figure 2.1 dashed line) exhibit a) a  
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Figure 2.1:  Reproducibility of fast and slow domains. 
Fast and slow electrically evoked responses are recorded by fast scan cyclic voltammetry with carbon 
fiber microelectrodes in the dorsal striatum of isoflurane-anesthetized rats.  In this and subsequent 
figures, the open symbols mark the beginning and end of the stimulus and the dotted lines show the 
SEM of the individual data points in each trace.  These responses are the average (±SEM) of multiple 
individual responses (n= 6 fast and 8 slow) each recorded in a different rat with a different electrode.  
The fast and slow responses were obtained with identical procedures except for the stimulus duration 
(200 ms in the case of fast responses and 3 s in the case of slow: see text for full explanation).  
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slow onset when the stimulus starts (DA is non- or barely-detectable after the first 200 ms of the 
stimulus), b) short-term facilitation of the evoked response (the response rises more rapidly as the 
stimulus continues), c) a delay in clearance (overshoot) after the stimulus ends, and d) slow DA 
clearance. 
The voltammetric responses in Figure 2.1 and subsequent figures are the average of a group of 
responses recorded in multiple animals.  The dotted lines above and below the average responses show 
the SEM of each data point: individual error bars are omitted for clarity because there are so many data 
points (10 s-1).  The fast response in Figure 2.1 is the average (± SEM) of n=6 individual responses 
recorded with 6 different carbon fiber microelectrodes in 6 different rats.  The slow response (Figure 
2.1) is the average (± SEM) of n=8 responses recorded with 8 different carbon fiber microelectrodes in 8 
different rats.  So, Figure 2.1 contains data from 14 rats in total.  Figure 2.1 establishes that the domain-
dependent evoked responses are reproducible between subjects. 
Slow domains are readily identified in all rats.  However, recording from fast domains requires 
optimization of the placement of the voltammetric electrode (May and Wightman, 1989a, Kawagoe et 
al., 1992, Garris et al., 1994, Garris et al., 2003, Venton et al., 2003).  Optimization involves lowering the 
electrode in small increments (50-100 μm) and repeating the stimulus at each new recording site.  To 
confine this study to the dorsal striatum, the electrodes were lowered by no more than 1 mm.  If a fast 
domain was not identified by optimization, slow responses were collected: we did not attempt multiple 
or deeper electrode penetrations during this study.  A fast site is identified in two ways.  First, evoked 
DA release is observed upon the very first voltammetric scan, which is performed 100 ms after the 
stimulus begins.  Second, the response exhibits short-term inhibition, i.e. the rate of evoked overflow 
during the second 100 ms of the stimulus is less than during the first 100 ms.  These characteristics are 
completely and obviously different from those associated with slow responses wherein evoked DA 
release is delayed and exhibits short term facilitation.  In this and prior studies we have adopted the 
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practice of limiting the duration of the stimulus in fast domains to 200 ms.  There are two reasons for 
this.  First, beyond 200 ms the fast responses fade, i.e. the DA signal decreases even though the stimulus 
continues, due to the onset of autoinhibition induced by the evoked increase in extracellular DA: the fast 
responses, therefore, are highly transient (Moquin & Michael 2009).  Second, if the stimulus continues 
beyond 200 ms, a slow response is observed.  This implies that the dimensions of the fast domain is 
smaller than the length of the electrode such that the electrode is partially located in a fast domain and 
partially located in a slow domain (please also see Figure 2.8, below).  We previously labeled this mix of 
fast and slow characteristics as a hybrid response (please see Moquin & Michael 2009 for additional 
details and examples of the hybrid response).  
2.3.2:  Domain-dependent effects of nomifensine: slow domains 
Nomifensine has multiple effects on slow responses (Figure 2.2a: this figure includes the slow pre-drug 
response from Figure 2.1 for comparison).  The post-nomifensine response (Figure 2.2a) is the average 
(±SEM) of the recordings in the same group of 8 rats.  Nomifensine significantly (p<0.005) increased the 
initial rate of evoked overflow during the first 200 ms of the stimulus (Figure 2.2b), eliminated the 
tendency of the signal to rise more rapidly as the stimulus continued (Figure 2.2a: the rising phase of the 
post-nomifensine response is nearly linear rather than curved upwards) and significantly increased the 
amplitude and duration of the signal overshoot (see Figure 2.6).  Nomifensine did not significantly affect 
the slope of the initial linear segment of the DA clearance profile (Figure 2.2c) but slowed the nonlinear 
segment after the DA signal fell below a DA concentration near 4 μM (see Figure 2.2a inset for a 
comparison of DA clearance starting at a concentration of 4 μM). 
In the pre-drug condition, 200-ms stimuli evoked little-or-no detectable response in slow 
domains (Figure 2.3 blue).  However, responses were clearly detected after nomifensine administration  
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Figure 2.2:  Effect of nomifensine on the slow domain: 180 pulse stimulation. 
Nomifensine (20 mg/kg i.p.) affects evoked responses in slow domains.  Figure 2.2a) Average (±SEM, 
n=8) of individual responses.  Inset: Nomifensine slows the nonlinear segment of DA clearance below 4 
μM.  Figure 2.2b) Nomifensine significantly increases the rate of evoked overflow during the first 200 ms 
of the stimulus ( p<0.005, paired t-test).  Figure 2.2c) Nomifensine has no effect on the rate of linear 
DA clearance during the descending phase of the response. Comparison of the clearance profiles during 
the final 4 μM of each response (inset) shows that nomifensine slowed the nonlinear phase of clearance 
in the slow domain.  
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Figure 2.3:  Effect of nomifensine on the slow domain: 12 pulse stimulation. 
Pre- and post-nomifensine responses (average ±SEM, n=8) recorded in slow domains using a 200 ms 
stimulus duration.   
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(Figure 2.3 red).  The onset of these responses was delayed with respect to the start of the stimulus: in 5 
of 8 cases the onset of the response occurred after the end of the stimulus. 
2.3.3:  Domain-dependent effects of nomifensine: fast domains 
Nomifensine has multiple effects on fast responses (Figure 2.4a: this figure includes the fast response 
from Figure 2.1 for comparison), however, these are distinct from the effects observed in slow domains.  
The post-nomifensine response is the average (± SEM) of the recordings in the same group of 6 rats.  
Nomifensine did not affect the initial response rate during the 200 ms stimulus (Figure 2.4a and 2.4b), 
dramatically increased the duration and amplitude of the stimulus overshoot (see also Figure 2.6), 
significantly (p<0.0005) decreased the slope of the initial linear segment of the clearance profile (Figure 
2.4a and 2.4c) and also slowed the nonlinear segment of the DA clearance profile. 
2.3.4:  Domain-dependent effects of nomifensine: comparisons 
To emphasize and clarify the domain-dependent actions of nomifensine, we report the initial response 
rates (0-200 ms) and linear clearance rates normalized with respect to their pre-nomifensine values 
(Figure 2.5).  Nomifensine significantly increased the normalized initial response rate in slow but not fast 
domains (Figure 2.5a).  According to 2-way ANOVA (details provided in the Figure 2.5 legend), the drug 
treatment (pre- and post-nomifensine, p<0.002) and interactions (p<0.002) are significant.  Nomifensine 
significantly slowed the normalized rate of linear DA clearance in fast but not slow domains (Figure 
2.5b): the drug treatment (p<0.000002) and interactions (p<0.000005) are significant. 
Nomifensine significantly affected the duration and amplitude of the overshoot after the end of 
the stimulus (measured according to the guidelines in Figure 2.4a).  Nomifensine significantly increased 
the overshoot duration (p<0.000005) but to a greater extent in fast domains (Figure 2.6a).  Nomifensine  
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Figure 2.4:  Effect of nomifensine on the fast domain: 12 pulse stimulation. 
Nomifensine affects evoked responses in fast domains.  Figure 2.4a) Average (±SEM, n=6) of individual 
responses.  The guidelines show how the duration (1) and amplitude (2) of the overshoot are defined 
(see Figure 6).  Figure 2.4b) Nomifensine does not affect the initial rate of evoked overflow during the 
first 200 ms of the stimulus.  Figure 2.4c) Nomifensine significantly decreases the slope of the linear 
segment of DA clearance ( p < 0.0005, paired t-test).    
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Figure 2.5:  Normalized domain dependent effects of nomifensine. 
The normalized effects of nomifensine are domain-dependent.  The initial rates of overflow (Figure 2.5a) 
and linear clearance (Figure 2.5b) are normalized with respect to their pre-nomifensine values.  Figure 
2.5a) Nomifensine significantly increased the normalized initial rate of overflow in slow but not fast 
domains (, 2-way ANOVA with repeated measures: drug treatment (pre- and post-nomifensine) 
F(1,12) = 14.517, p < 0.002, interactions F(1,12) = 14.771, p < 0.002).  Figure 2.5b) Nomifensine 
significantly decreased the rate of linear DA clearance in fast but not slow domains (§ 2-way ANOVA 
with repeated measures: treatment F(1,12) = 79.332, p < 0.000002, interactions F(1,12) = 62.172, p < 
0.000005).  
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Figure 2.6:  Effect of nomifensine on DA overshoot. 
Nomifensine affects signal overshoot, a measure of the delay at the end of the stimulus (see Figure 2.4a 
for guidelines). Figure 2.6a) Nomifensine significantly increased the overshoot duration to 0.60 sec in 
the slow domains and to 0.85 sec in the fast domain ( 2-way ANOVA with repeated measures: 
treatment F (1,12) = 64.152, p < 0.000005, interactions F (1,12) = 7.783, p < 0.02). Figure 2.6 b) 
Nomifensine significantly increased the overshoot amplitude in fast but not slow domains (§ two way 
ANOVA with repeated measures: domains (fast and slow) F(1,12) = 5.264, p < 0.05, treatment F(1,12) = 
51.659, p < 0.000002, interactions F(1,12) = 23.166, p < 0.0005).  
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significantly increased the overshoot amplitude (p<0.00002) but to a greater extent in fast domains 
(Figure 2.6b: 2-way ANOVA details are in the figure legend). 
In both fast and slow domains, nomifensine slowed the rate of non-linear clearance, as expected 
given that nomifensine is a competitive DAT inhibitor (Wightman et al., 1988a, Wu et al., 2001b). 
2.3.5:  Electron Microscopy 
Electron microscopy (Figure 2.7) exposes the ultrastructural details of the tissue architecture in the 
vicinity of the electrode track.  This image was obtained, as previously described (Peters et al., 2004) by 
starting above the recording site where the track formed by the glass barrel of the electrode is obvious 
and following the track ventrally until it exhibits dimensions commensurate with the diameter of the 
carbon fiber.  In this image, the track is visualized as an approximately round spot of red blood cells that 
apparently filled the void created when the electrode was explanted from the tissue.  Because these red 
blood cells are outside vessels, they were not removed during the perfusion.  The track has a well-
defined boundary where the red blood cells meet the tissue.  Numerous identifiable elements are 
present in close proximity to this boundary (see Figure 2.7 legend for details), including axon terminals 
forming symmetric or asymmetric synaptic junctions.  Numerous synaptic junctions with normal 
morphology are present less than 1 μm from the track boundary.   
 
2.4:  DISCUSSION 
This study reinforces the presence of distinct fast and slow DA kinetic domains in the rat dorsal striatum 
(Figure 2.1) and demonstrates that the actions of nomifensine on evoked DA responses are domain-
dependent.  Although several previous studies have examined nomifensine’s actions on evoked DA 
(Jones et al., 1995b, Garris et al., 2003, Robinson and Wightman, 2004, Borland et al., 2005, Benoit-
Marand et al., 2011), none addressed the domain-dependency.  As discussed in detail below, the impact  
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Figure 2.7:  Electron micrograph of the carbon fiber microelectrode track in the dorsal striatum. 
Electron microscopic images of a carbon fiber track in the rat dorsal striatum.  Figure 2.7A) At lower 
magnification, the track appears as an approximately round spot filled with red blood cells (rbc) that 
apparently fill the void formed when the electrode is explanted.  Also visible are a single reactive 
monocyte (m) and the cell body of a neuron (n). The regions of interest outlined by boxes are shown at 
higher magnification in Figure 2.7B, Figure 2.7C. Blood cells are directly apposed to neuronal structures 
(arrowheads) or separated from them by a slightly larger space (asterisk in B). The morphological 
appearance of these neuronal structures is normal. Multiple axon terminals (at) form symmetric (white 
arrows) or asymmetric synapses (black arrows) onto dendritic shafts or spines, respectively. Scale bar in 
Figure 2.7A corresponds to 2 μm for Figure 2.7A and the scale bar in Figure 2.7C corresponds to 0.25 μm 
for Figure 2.7B and Figure 2.7C.  
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of nomifensine on evoked DA responses cannot be explained solely by its ability to increase the effective 
KM of DA uptake, which points to an additional action of nomifensine on DA.  Based on the findings of 
this study, we propose that additional action involves an interaction with restricted DA diffusion 
processes in the extracellular space. 
2.4.1:  Detection of DA domains 
In our experience, slow domains are found throughout the dorsal striatum (see Materials and Methods 
for coordinates) but it is necessary to optimize the electrode placement in order to identify fast 
domains.  Optimization to find DA “hot spots” is a common procedure (May and Wightman, 1989a, 
Kawagoe et al., 1992, Garris et al., 1994, Garris et al., 2003, Venton et al., 2003), but relatively little 
attention has been devoted to the “cold spots”, which have been viewed as non-DAergic sites (Venton 
et al., 2003).  Our recent reports, however, demonstrated that the cold spots are slow DAergic domains 
wherein DA terminals are autoinhibited (Moquin and Michael, 2009, Wang et al., 2010).  Although 
evoked DA release in the striatum is generally described as heterogeneous (Wightman et al., 1988a, May 
and Wightman, 1989b, Kawagoe et al., 1992, Zahniser et al., 1999, Venton et al., 2003), the fast and 
slow responses are reproducible across subjects (Figure 2.1).  
Our findings provide some preliminary indication of the architecture of the domains.  The 
schematic in Figure 2.8 depicts fast domains as “islands” on a slow background, with one microelectrode 
traversing a fast island and a second contained entirely within the slow “sea”.  The idea that fast 
domains are smaller than the length of the electrodes (200 μm) rests on the observation of hybrid 
responses, consisting of both fast and slow components, when the stimulus extends beyond 200 ms 
(Moquin and Michael 2009).  The spacing between the fast domains appears to be more than the length 
of the electrode (200 μm), since many recording sites produce only the slow response. 
Equation 2.1                           
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Figure 2.8:  Schematic representation of the proposed domain architecture. 
Schematic of the proposed domain architecture depicting island-like fast domains (blue circles) on a 
slow background (pale green).  One electrode is depicted as traversing a fast island while a second 
electrode is depicted within the slow domain.  Lowering the second electrode to deeper recording sites 
would not result in detection of a fast domain.  
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2.4.2:  A model for evaluating evoked responses 
Evoked DA responses are often evaluated with a model that combines the rates of DA release and 
clearance (May et al., 1988, Wightman et al., 1988a, Kennedy et al., 1992, Wu et al., 2001a, Michael et 
al., 2005): where [DA] is the extracellular DA concentration, t is time, f is the stimulus frequency, [DA]p is 
the concentration of DA released per stimulus pulse and Vmax and KM are the maximal rate and Michaelis 
constant, respectively, of DA uptake.  So,         is the rate of evoked DA release and 
         
       
 is the 
rate of DA uptake.  Equation 2.1 was previously presented as Equation 1.5. 
 According to this model (see Supplementary Information), the difference between the rate of 
evoked release and DA uptake determines the rising phase of the evoked response, whereas uptake 
alone determines the descending phase of the response.  If the DA concentration sufficiently exceeds 
KM, then the descending phase of the response is predicted to exhibit an initial linear segment, reflecting 
the zero-order kinetics of saturated transporters (V = Vmax), followed by a nonlinear segment when 
transporters are no longer saturated (V ≈ k[DA], where k = Vmax/KM) (Peters and Michael, 2000, Wu et al., 
2001b). 
Measured responses sometimes exhibit delays at the beginning and end of the stimulus.  These 
delays are not described by Equation 2.1 and are usually attributed to diffusion across a gap between 
the electrode and DA terminals (Kristensen et al., 1987, Engstrom et al., 1988, Garris et al., 1994, Jones 
et al., 1995b).  Such a gap might be caused by the use of a Nafion film or damage to the tissue adjacent 
to the electrode.  The delays can be removed with a deconvolution algorithm.  Once the responses are 
deconvoluted, the model can be used to determine “intrinsic” values [DA]p, Vmax, and KM (Engstrom et 
al., 1988, Wightman et al., 1988a, May and Wightman, 1989a, Kawagoe et al., 1992, Garris et al., 1994, 
Wu et al., 2001b, Venton et al., 2002, Garris et al., 2003).  Without deconvolution, the slopes of the 
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responses can be used to estimate “apparent” kinetic values, which are likely to include diffusion 
contributions since diffusion acts on local DA concentrations (Rice and Cragg, 2008).  
2.4.3:  Evaluating slow responses 
The rising phase of slow responses exhibits an obvious delay when the stimulus starts (the onset is 
delayed, begins slowly, and speeds up as the stimulus continues).  But, rather than diffusion, this delay is 
due to autoinhibition: the delay is eliminated by the D2 antagonist, raclopride, and enhanced by the D2 
agonist, quinpirole (Moquin and Michael, 2009).  Because the delay is not due to diffusion, the 
deconvolution algorithm cannot be used, so we analyzed these responses for apparent kinetic 
parameters (we have not yet attempted to elaborate on Equation 2.1 to include autoinhibition: 
however, see (Montague et al., 2004)).  Qualitatively, Equation 2.1 predicts that a competitive uptake 
inhibitor, which increases the effective KM (Miller and Tanner, 2008), is expected to a) increase the slope 
of the rising phase of the response, b) have no effect on the rate of the initial linear segment of the DA 
clearance profile, and c) increase the concentration at which the clearance kinetics transition from zero- 
to first-order (Peters and Michael, 2000, Wu et al., 2001b).  Nomifensine produces all of these predicted 
effects in slow domains (Figure 2.2). 
Two aspects of the post-nomifensine response in slow domains deserve further consideration.  
First, nomifensine eliminated the response delay at the start of the stimulus.  This reinforces the 
conclusion that the delay is not diffusional because DA terminals must be present very near the 
electrode in order to detect DA release so quickly (100 ms) after the stimulus begins.  Because 
nomifensine targets DAT, this observation also reveals the presence of functional DATs very near to the 
electrode, and in the dorsal striatum only DA terminals express this protein (Rocha et al., 1998).  The 
detection by EM of axon terminals in close proximity to the electrode track (Figure 2.7) also supports 
this conclusion.  An alternative possibility is that nomifensine eliminated the onset delay by triggering 
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the desensitization of autoreceptors (Katz et al., 2010): at present, we consider this mechanism unlikely 
because a) uptake inhibition is expected to increase the rate overflow and b) in our hands the D2 agonist 
quinpirole further suppressed evoked release, which is not the expected consequence of desensitization 
(Moquin and Michael, 2009).  Second, even though nomifensine decreased the onset delay, it increased 
the response overshoot at the end of the stimulus (Figure 2.6).  The asymmetry of nomifensine’s impact 
on the response delays (i.e. decreasing the delay at the start of the stimulus and increasing the delay at 
the end of the stimulus) is very surprising and has not been commented on before in the literature.  As 
mentioned above, delays are usually attributed to a diffusion gap, but a diffusion gap causes 
symmetrical delays, i.e. a larger gap will increase the delay at both the start and end of the stimulus (see 
Supplementary Information).  As discussed below, the asymmetry of the delays observed in this study 
require careful consideration. 
Analysis of the slope of the rising and descending phases of the slow responses yields a set of 
apparent DA kinetic parameters (Figure 2.2b and 2.2c).  The uniformity of the slow domain responses 
implies an absence of concentration gradients during these measurements, so the apparent values are 
probably not greatly affected by diffusion.  In that case, the apparent rate of DA clearance reflects the 
activity of transport, which primarily occurs via the DAT (Moron et al., 2002, Torres, 2006), with possible 
contributions from other transporters (Wu et al., 1998, Moron et al., 2002, Larsen et al., 2011).  
However, our experiments were not designed to resolve the contribution of individual transporters.  The 
apparent rates must be viewed as semi-quantitative because EM analysis (Figure 2.7) shows that the 
electrodes are partially blocked, in this instance by a reactive monocyte (an immune cell) near the 
electrode track: such blockage of the electrode surface leads to underestimation of DA concentrations 
and rates.  Assuming that the blockage is constant over the short duration of these experiments, 
proportional comparisons of the apparent clearance rates are justified (Figure 2.5). 
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2.4.4:  Evaluating fast responses 
In fast domains, the evoked responses (pre-nomifensine) exhibit no delay when the stimulus starts or 
stops.  The responses exhibit all the main features predicted by Equation 2.1 (see Supplementary 
Information): a) the signal rises without delay when the stimulus begins, b) the signal slows down as the 
stimulus continues (because the rate of DA clearance increases as the DA concentration rises), and c) the 
DA clearance profile exhibits an initial linear segment (zero-order clearance) followed by a non-linear 
segment (the expected conversion to first-order clearance).  This supports the view that the fast 
responses are affected by neither autoinhibition nor diffusion gaps. 
Some features of the post-nomifensine fast responses are also consistent with the kinetic model 
(Equation 2.1).  The most obvious is the overall decrease in the rate of DA clearance after the end of the 
stimulus (see Supplementary Information), since nomifensine is a DAT inhibitor.  On the other hand, 
nomifensine had no effect on the initial rate of evoked release (Equation 2.1 predicts an increase) and 
dramatically increased the duration and amplitude of the overshoot (Equation 2.1 does not predict 
overshoot).  Thus, as in slow domains, nomifensine has a highly asymmetric effect on the response 
delays not predicted by the kinetic model.  
It is important to emphasize that we cannot use the deconvolution algorithm to remove the 
overshoot from the post-nomifensine fast responses.  The delay in these responses is highly asymmetric, 
whereas the deconvolution was developed to correct symmetric delays arising from diffusion gaps (see 
Supplementary Information).  In prior studies, diffusion gaps were attributed to Nafion films, which 
were not used in this study, or tissue damage.  Although tissue damage is a concern when implanting 
devices into brain tissue (Jaquins-Gerstl and Michael, 2009, Jaquins-Gerstl et al., 2011), EM shows no 
evidence of damage-related diffusion gaps in our studies (Figure 2.7).  Moreover, the pre-nomifensine 
response is not delayed, so there is no evidence for diffusion gaps in the fast recording sites.   
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It is necessary to consider whether the proposed island-like geometry of the fast domains 
(Figure 2.8) contributes to the overshoot.  For example, it is often mentioned (Nicholson, 1995, Borland 
et al., 2005) that uptake inhibition provides DA with more time to diffuse further from its source. 
However, if molecules are produced within a small source, the rapid outward diffusion into an ever-
expanding volume leads to rapid dilution at increasing distances from the source: this makes overshoots 
less likely, not more likely.  For example, Rice and Cragg calculated the diffusion and uptake of DA after 
release from a single vesicle (Rice and Cragg, 2008).  Their calculations show that even in the absence of 
uptake (see their Figure 2.1) DA in the striatum reaches its peak extracellular DA concentration within a 
few milliseconds of the quantal event, whereas the overshoot duration observed during our study 
reached as long as 850 ms (Figure 2.6).  
It is also known that DAT inhibitors can activate DA release from intraneuronal storage pools 
(Ewing et al., 1983, Venton et al., 2006).  It is possible that activation of storage pools could contribute 
to the post-nomifensine response observed during this study.  However, additional release would not by 
itself lead to asymmetry of the response delays, which are the focus of the remainder of this discussion. 
2.4.5:  A role for restricted diffusion in the effects of nomifensine 
As explained above, the existing model of DA kinetics (Equation 2.1), even when adjusted for a diffusion 
gap (Supplementary Information), cannot explain nomifensine’s prominent impact on the asymmetry of 
the evoked responses.  Thus, it appears that DA uptake is somehow coupled to extracellular DA diffusion 
in a manner not yet fully understood. We now present a new explanation that invokes restricted DA 
diffusion in the extracellular space.  
The overshoot in the post-nomifensine fast response is remarkable in that its duration of 850 ms 
is 4-times longer than the stimulus itself (Figures  2.4 and 2.6).  A similar overshoot occurs in slow 
domains when the stimulus is likewise limited to 200 ms (see Figure 2.3 and Figure 2.9).  The overshoots  
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Figure 2.9:  Normalized fast and slow nomifensine induced overshoot kinetics. 
The “pure overshoots” observed in fast and slow domains post-nomifensine in response to a 200 ms 
stimulus.  The two responses are normalized to their maximum amplitudes.  The blue line was obtained 
from the fast domain by subtracting the pre-drug response from the post-nomifensine response.  The 
red line is from Figure 2.3. 
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show that DAT inhibition allows DA to continue diffusing to the recording electrode long after DA 
terminals stop releasing DA.  But, the large amplitude of the post-nomifensine responses shows that DA 
does not suffer substantial dilution during this process, so the diffusion occurs over a short distance.  
This combination, long diffusion time combined with little dilution, is highly suggestive of a restricted 
diffusion process. 
In this restricted diffusion scenario, DA molecules are released near the electrode but are 
restricted from diffusing to the electrode and thus go undetected.  There are several ways in which 
diffusion can be restricted but an obvious candidate in brain tissue is the tortuosity of the extracellular 
space (Nicholson, 1995, Nicholson and Sykova, 1998, Sykova and Nicholson, 2008).   Because the 
extracellular space is tortuous, it is possible that some DA molecules are released into confined spaces 
connected to the surroundings by narrow passageways or bottlenecks.  If diffusion through the 
bottlenecks is slow, DA could be taken up faster than it can diffuse to the surrounding.  In this scenario a 
DAT inhibitor would promote the escape, and thus detection, of DA with the long-duration overshoot 
reflecting the rate of DA diffusion through the bottlenecks.   
This restricted diffusion scenario explains the asymmetric impact of nomifensine on the 
response delays as not all DA molecules are restricted from diffusing to the electrode.  The rapid onset 
of the fast response is presumably due to non-restricted molecules, whereas the overshoot is due to 
restricted molecules. The restricted diffusion concept also explains the asymmetry of nomifensine’s 
actions on the slow responses.  According to this new explanation of events, the decreased delay in the 
onset of the response is attributable, in the normal way, to a decreased rate of uptake (according to 
Equation 2.1, less uptake during the stimulus should increase the response rate), while the overshoot 
derives from overcoming restricted diffusion.   
The literature offers precedent for this restricted diffusion concept.  It was previously invoked by 
Floresco et al. (Floresco et al., 2003) to explain the effects of uptake inhibition on the detection of DA by 
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microdialysis.  Floresco et al. suggested that DA molecules are restricted to synaptic clefts until the DAT 
is inhibited.  This idea, however, is at odds with the concept that DA molecules escape rapidly from 
striatal synapses (Garris et al., 1994), given their nanometer dimensions (see, for example, Figure 2.7).  
Despite this caveat, it is interesting to note that the restricted diffusion model appears to be consistent 
with DA measurements by both voltammetry and microdialysis.  
Other mechanisms of restricted diffusion are known.  For example, diffusion can be restricted if 
molecules interact with stationary binding sites (see (Sykova and Nicholson 2008) and section 8.4 of 
(Crank, 1956)).  In this case, molecules would not ‘break through’ to the electrode until the binding sites 
were completely occupied, which could be a consequence of uptake inhibition.  Further investigation 
will be required to explain the precise mechanism by which DA diffusion is restricted but our results 
clearly suggest that DAT interacts with a complex diffusion process to maintain control of extracellular 
DA concentrations.  Nomifensine’s actions cannot be explained solely on the basis of an increase the KM 
of DA uptake.  
 
2.5:  CONCLUSION 
This study reinforces the existence of distinct DA dynamical domains in the dorsal portion of the rat 
striatum and identifies the domain-dependent actions of nomifensine.  The asymmetrical effects of 
nomifensine on the domain-selective responses suggest that DAT interacts with complex DA diffusion 
processes in the striatum.  The restricted diffusion model is interesting in light of our previous reports 
that local differences in basal DA concentrations cause, via autoinhibition, the domain-dependent DA 
dynamics (Moquin and Michael, 2009, Wang et al., 2010).  These local differences in DA concentration, 
while detected by voltammetry, are difficult to understand unless the local DA concentrations are 
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somehow prevented from freely mixing.  Thus, the present study not only reinforces the existence of the 
domains but also contributes to explaining them. 
 
2.6:  SUPPLEMENTARY INFORMATION 
2.6.1:  The stability of evoked DA in the rat striatum 
This study relies on comparisons of evoked DA responses in individual rats before and after the 
administration of nomifensine. This common practice relies on the well-known stability of evoked DA 
responses in the rat striatum (see references in main text).  Prior studies have mainly focused on fast 
type responses recorded after optimization of the electrode placement.  Figure S2.1 illustrates the 
stability of the slow responses by means of a representative example of multiple slow responses 
collected in an individual rat at 5, 15, and 45 minutes after an initial, baseline response.  The delay in 
onset of the response and the rate of DA clearance after the end of the stimulus are both consistent. 
2.6.2:  Using Equation 1 to model competitive DAT inhibition 
Equation 2.1 of the main text is a mathematical model used frequently to quantitatively evaluate evoked 
DA responses in terms of the intrinsic kinetic parameters [DA]p, Vmax, and KM.   A main theme of this 
study is that this standard model does not comprehensively fit the collection of evoked responses 
recorded in both the fast and slow domains, before and after the administration of nomifensine.  This 
points to a major conclusion of our study, i.e. that nomifensine appears to do more than just increase 
KM.  In this Supplementary Information document, we present modeled evoked responses, with and 
without the effects of a diffusion gap, to examine the contrast between the modeled and measured 
results. 
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Supplementary Figure S2.1:  Reproducibility of stimulated release in the slow domain. 
The kinetic response of the slow domain is reproducible over time.  Shown here are the evoked DA 
overflow responses to consecutive 3 sec, 60Hz stimulations in the slow domain of a single rat without 
altering the stimulation or working electrode positions or parameters.  The initial response delay and 
linear clearance rate are consistent after 5, 15, and 45 minutes following collection of the baseline 
reading at t = 0. 
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Figure S2.2a shows evoked responses calculated with Equation 2.1 using some standard stimulus 
conditions (60 Hz, 1 s) and intrinsic kinetic parameters ([DA]p = 0.1 μM, Vmax = 5 μM/s, and KM = 0.2 μM 
and 0.8 μM: these two values of KM are typical pre-and post-nomifensine values).  It is important to 
emphasize that these modeled responses are presented only to illustrate their essential features, not as 
a fit to any of the measured responses reported in the main text. 
 The rising phase of the modeled responses are always ‘curved-downwards,’ i.e. the response 
rate decreases as the stimulus proceeds.  Mathematically, this occurs because the rate of evoked 
release,        , is constant while the rate of DA clearance, 
         
       
, increases as the DA 
concentration increases.  Whereas the modeled responses are curved-downwards, the measured slow 
responses are ‘curved-upwards,’ i.e. they begin slowly but get faster as the stimulus proceeds.  This 
contrast between the modeled and measured responses is the basis for the statement in the main text 
that model does not predict the measured slow responses. 
 Figure S2.2a compares responses modeled with two different values of KM to predict the actions 
of a competitive uptake inhibitor.   A key point is that competitive uptake inhibition is not expected to 
substantially alter the initial slope of the clearance phase of the response.  This is the basis for claiming, 
as we do in the main text, that the decrease in clearance slope of the fast responses caused by 
nomifensine is paradoxical.  A slight decrease in initial slope might be expected if the pre-drug response 
did not reach sufficient concentrations to exceed KM, but the fast responses well exceed the reported 
KM.   
 In the case of fast responses, nomifensine did not alter the rising phase of the stimulus response 
during the 200 ms stimulus.  This is another observation inconsistent with the model, which predicts 
that the slope of the response should increase when the rate of clearance decreases.  In the case of 
Figure S2.2a, the signal is increased nearly 40% after the first 100 ms of the stimulus (see the first “data 
point” on the modeled responses). 
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Supplementary Figure S2.2:  Simulated effect of increasing KM on evoked DA overflow. 
Simulations, according to equation 2.1, modeling the effect of increasing KM do not reproduce the 
observed effects of nomifensine in the fast domain.  Figure S2.2a) The simulation modeling an increase 
in KM from 0.2 μM to 0.8 μM (representative of competitive DAT inhibition by nomifensine) in the 
absence of diffusion does not produce the overshoot and subsequent slowing of linear clearance 
observed in the fast domain.  Figure S2.2b) Incorporation of a 10 μm diffusional gap into the model 
produces a small symmetrical distortion at the beginning and end of stimulation which also fails to 
mimic the large asymmetric overshoot observed in the fast domain after nomifensine.  
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Figure S2.2b repeats the calculation in Figure S2.2a but includes the effect of a 10 μm diffusion gap 
between the electrode and the site of DA release and uptake.   A finite element simulation algorithm 
was used to calculate the diffusion effect.   A diffusion gap in the in vivo experiments might arise from 
the use of Nafion films (which were not used in this study) or as consequence of penetration injury 
caused by the electrode.  Figure S2.2b shows two important features of the response delays expected in 
the presence of a diffusion gap.  First, the modeled delays when the stimulus starts and stops are 
symmetrical: in Figure S2.2b the delays are both about 200 ms.   Second, the delay even from a diffusion 
gap as large as 10 μm should be relatively minor, i.e. only about 200 ms and far smaller than the 800 ms 
observed in fast domains after nomifensine.  These features of the modeled response delays, i.e. that 
they are symmetrical and relatively minor, is the basis for claiming, in the main text, that the delays 
observed by voltammetry in the striatum do not conform to diffusion gap expectations.  First, the delays 
are symmetrical and, especially in the fast domains post-nomifensine, are much longer than can be 
explained be even a large diffusion gap.  The EM result (Figure 2.7 of the main text) shows that any 
diffusion gap due to penetration injury is much smaller than 10 μm. 
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3.0:  RESTRICTED DIFFUSION OF DA IN THE RAT DORSAL STRIATUM 
Adapted with revisions from Taylor et al. 2013.  Reproduced with permission. 
 
 
 
3.1:  INTRODUCTION 
Central dopamine (DA) systems participate in numerous aspects of brain function (Goto et al., 2007, 
Obeso et al., 2008) and their dysfunction contributes to a broad array of disorders and diseases 
including Parkinson’s disease (Pavese et al., 2011), schizophrenia (Mizuno et al., 2012) and attention 
deficit hyperactivity disorder (Ludolph et al., 2008).  Broadly speaking, the physiological function of the 
DA molecules themselves is to bind to post- and pre-synaptic receptors to modulate the activity of the 
postsynaptic targets (Korchounov et al., 2010) and to self-regulate DAergic activity (Starke et al., 1989), 
respectively.  Consequently, numerous drugs act by modulating extracellular DA concentrations (e.g. L-
DOPA, MAO inhibitors and inhibitors of the dopamine transporter (DAT) (Church et al., 1987, Brannan et 
al., 1995, Hornykiewicz, 2002, Schiffer et al., 2006)) or by modulating or mimicking the binding of DA to 
its receptors (DA agonists and antagonists) (Seeman et al., 1976, Kapur et al., 1999).   Some of the drugs 
that target DA systems have important therapeutic applications (Gottwald and Aminoff, 2011, Guo et 
al., 2012) while others have high potential for illicit abuse (Sulzer et al., 1995, Phillips et al., 2003, 
Hollander and Carelli, 2007): some therapeutic drugs are also abused (White et al., 2006).  Thus, it is 
significant to know the extracellular DA concentration per se, to know the kinetics of DA release and 
clearance that determine the concentration, and to know the actions of drugs that target DA systems.    
Recently, we have demonstrated that the DA terminal field in the rat dorsal striatum contains a 
patchwork of kinetic spatial domains.  The fast and slow domains were brought to light by recordings of 
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extracellular DA with fast-scan cyclic voltammetry (FSCV) at carbon fiber microelectrodes during 
electrical stimulation of the medial forebrain bundle (MFB).  The extracellular concentration of DA, the 
kinetics of DA release and clearance, the short-term plasticity of DA release, and the actions of DA-
targeting drugs are each domain-dependent (Moquin and Michael, 2009, Wang et al., 2010, Moquin and 
Michael, 2011, Taylor et al., 2012).  The patchwork phenomenon brings a new perspective to the often 
mentioned heterogeneity of striatal DA (Wightman et al., 1988a, May and Wightman, 1989b, Kawagoe 
et al., 1992, Garris and Wightman, 1995, Moquin and Michael, 2009), because DA is notably 
homogeneous within the fast and slow domains (Taylor et al., 2012).  Although the patchwork has only 
recently been described, there is precedence for the phenomenon as DA is known to function on 
multiple time courses (Schultz, 2007) and local differences in short-term plasticity of DA have been 
reported before (Cragg et al., 2002, Cragg, 2003, Montague et al., 2004, Kita et al., 2007, Chadchankar 
and Yavich, 2011).   
Our prior findings indicate that the slow domains exist under a state of tonic autoinhibition 
derived from a tonic basal extracellular DA concentration sufficient to activate presynaptic D2 
autoreceptors (Moquin and Michael, 2009, Wang et al., 2010).  In contrast, such an autoinhibitory tone 
is absent in the fast domains (Moquin and Michael, 2009, Wang et al., 2010).  This implies the presence 
of a persistent DA concentration gradient between the extracellular spaces of fast and slow domains.  At 
present, however, it is unclear why DA extracellular diffusion (Engstrom et al., 1988, Nicholson, 1995, 
Peters and Michael, 2000, Rice and Cragg, 2008, Sykova and Nicholson, 2008) would not eliminate the 
concentration gradient, hence the domain-dependent autoinhibitory tone.  Thus, the goal of the present 
study was to examine evoked DA responses in fast and slow domains of the dorsal striatum under a 
broader range of experimental conditions than used in our previous studies.  The evoked responses 
reported herein support the novel conclusion that DA’s ability to diffuse between the fast and slow 
domains is severely limited.  We discuss this conclusion in the context of the restrictions on extracellular 
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diffusion as described by Nicholson and coworkers (Hrabetova et al., 2003, Hrabetova and Nicholson, 
2004, Tao et al., 2005, Sykova and Nicholson, 2008).  
 
3.2:  MATERIALS AND METHODS 
3.2.1:  Carbon fiber electrodes 
A single carbon fiber (7-μm diameter, T650; Cytec Carbon Fibers LLC, Piedmont, SC, USA) was threaded 
into a borosilicate capillary (0.4mm ID, 0.6mm OD; A-M systems Inc., Sequim, WA, USA) and pulled to a 
fine tip using a vertical puller (Narishige, Los Angeles, CA, USA).  The tip was sealed with a low-viscosity 
epoxy (Spurr Embedding Kit; Polysciences Inc., Warrington, PA, USA) and the exposed fiber was trimmed 
to a length of 200 μm.  A drop of mercury established the electrical connection between the fiber and a 
nichrome wire (Nichrome; Goodfellow, Oakdale, PA, USA).  Electrodes were soaked for 30 minutes in 
isopropyl alcohol prior to use (Bath et al., 2000).  Post-calibration was carried out using freshly prepared, 
nitrogen-purged dopamine HCl (Sigma Aldrich, St. Louis, MO, USA) standard solutions in artificial 
cerebrospinal fluid (144 mM Na+, 1.2 mM Ca2+, 2.7 mM K+, 1.0 mM Mg2+, 149.1 mM Cl- and 2.0 mM 
phosphate, pH 7.4).  Concentrations in vivo were obtained using post calibration results. 
3.2.2:  Fast-scan cyclic voltammetry 
Voltammetry was performed with an EI 400 potentiostat (Ensman Instruments; Bloomington, IN, USA) 
under software control (CV Tar Heels v4.3, courtesy of Dr. Michael Heien, University of Arizona, Tucson, 
AZ, USA).  The voltammetric waveform consisted of 3 linear potential ramps starting at the rest potential 
of 0 V (vs. Ag/AgCl) first to +1.0 V, then to -0.5 V and back to 0 V at a scan rate of 400 V/s: the waveform 
was applied at a frequency of 10 Hz.  DA was identified by inspection of background-subtracted 
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voltammograms and quantified with the oxidation current between +0.5 and +0.7 V on the initial 
ascending potential ramp. 
3.2.3:  Surgical and stimulation procedures 
The University of Pittsburgh’s Institutional Animal Care and Use Committee reviewed and approved all 
procedures involving animals.  Male Sprague-Dawley rats (250 – 350 g; Hilltop, Scottsdale, PA, USA) 
were anesthetized with isoflurane (2.5% by volume O2) and maintained at a body temperature of 37˚C 
(Harvard Apparatus; Holliston, MA, USA).  Anesthetized rats were placed in a stereotaxic frame (David 
Kopf, Tujunga, CA, USA) with the incisor bar raised to 5 mm above the interaural line (Pellegrino et al., 
1979).  Dura mater was exposed by craniotomies and removed to allow insertion of the reference, 
working and stimulating electrodes.  Contact between the brain surface and a Ag/AgCl reference 
electrode was established via a salt bridge.  A carbon fiber electrode was implanted into the dorsal 
striatum (2.5 mm anterior to bregma, 2.5 mm lateral from bregma and 5-6 mm below the cortical 
surface).  A stainless steel, twisted bi-polar stimulating electrode (MS303/a; Plastics One, Roanoke, VA, 
USA) was aimed at the medial forebrain bundle (MFB, 2.2 mm posterior to bregma, 1.6 mm lateral from 
bregma, and 7-9 mm below the cortical surface) and lowered until evoked DA release was observed in 
the striatum (Ewing et al., 1983, Kuhr et al., 1984, Stamford et al., 1988).  The MFB stimulation was a 
biphasic, constant-current, square-wave waveform delivered by a pair of optical stimulus isolators 
(Neurolog 800, Digitimer; Letchworth Garden City, UK).  The stimulus pulse width was held constant at 
4 ms throughout this study.   
3.2.4:  Objective identification of fast and slow domains in the dorsal striatum 
All experiments described herein began with an initial procedure to position the recording carbon fiber 
electrode in an objectively identified fast or slow domain.  For this initial procedure, MFB stimulation 
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was performed with a frequency of 60 Hz and a current intensity of 250 μA.  Fast and slow domains 
were identified according to our previously described classification criteria (Moquin and Michael, 2009, 
Moquin and Michael, 2011, Taylor et al., 2012): fast domains were identified by robust evoked DA 
release during the first 100 ms of the stimulus and subsequent short-term depression of evoked release, 
whereas slow domains were identified by an initial delay and subsequent short-term facilitation of 
evoked release.  This classification scheme is objective because responses exhibiting short-term 
facilitation versus depression are easily discriminated.  The recording electrode was lowered from its 
initial vertical coordinate (5 mm below dura) in small increments (50-100 μm) and the stimulus repeated 
until a fast domain was identified: to restrict these experiments to the dorsal striatum, lowering was 
stopped after 1 mm (6 mm below dura) if no fast domain was identified and responses from the slow 
domain were recorded. 
3.2.5:  Experimental design 
Whereas our previous studies of the domain phenomenon were conducted with a single stimulus 
frequency and current intensity, herein we report evoked responses in objectively identified fast and 
slow domains (see previous paragraph) over a broader range of stimulus durations (12-180 pulses), 
frequencies (15-60 Hz) and current intensities (150-450 μA). 
We also investigated the effects of raclopride and quinpirole on evoked responses in 
nomifensine-treated rats.  First, recording carbon fiber electrodes were implanted in rats using the 
procedure, described above, for objective identification of fast and slow domains in dorsal striatum. An 
initial pre-drug stimulus response was recorded (200 ms, 60 Hz, 250 μA).  Nomifensine (20 mg/kg i.p.) 
was administered and a second stimulus response was recorded 30 min later (the initial and post-
nomifensine-only responses are not shown here: such responses are reported elsewhere (Taylor et al., 
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2012)).  Then, raclopride (2 mg/kg i.p.), quinpirole (1 mg/kg i.p.) or vehicle (PBS) was administered and a 
final stimulus response was recorded 30 min later (see Figure 3.4). 
In a separate experiment in 4 additional rats (see Figure 3.5), we examined the effects of 
nomifensine on low-frequency stimulus responses (15 and 30 Hz, 180 stimulus pulses, 250 μA).   
Davidson et al. (Davidson et al., 2000) reports that prolonged exposure to nomifensine 
decreases the sensitivity of carbon fiber electrodes to DA.  However, in our hands, the impact of 
nomifensine on evoked responses is robust so any major effect of nomifensine on the electrode 
sensitivity seems unlikely.  Moreover, in this study we compare the effects of raclopride and quinpirole 
under the same nomifensine pretreatment conditions, so we assume any effect of nomifensine would 
be equivalent and not affect the comparisons of major interest in this work. 
3.2.6:  Data analysis 
Current vs. time graphs were generated using the peak oxidation potential for DA.  Linear DA clearance 
rate was assessed by determining the slope of the descending phase of the response with an r2 > 0.96.  
The overshoot duration is the time period from the end of stimulation that DA continues to increase in 
amplitude, and the overshoot amplitude is the concentration of DA increase during that duration.  
Statistical analyses were by one- and two-way ANOVA with a repeated measures design as well as post 
hoc pairwise comparison of main effects using a 95% confidence interval (IBM SPSS Statistics 20 
software) and t-tests of independent (Figures  3.1, 3.3, and 3.4) or paired (Figure 3.5) samples. 
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3.3:  RESULTS AND DISCUSSION 
3.3.1:  Domain-dependent effects of stimulus intensity: 60 Hz, 180 pulses 
We recorded evoked DA release in objectively identified (see Methods) fast (Figure 3.1a, n=5) and slow 
(Figure 3.1b, n=8) domains of individual rats over a range of stimulus current intensities (150-450 μA, 
180 pulses, 60 Hz: the solid lines in Figures  3.1a-b are the averages (error bars omitted for clarity) of 
responses recorded in different rats: error bars and statistics are reported in Figures  3.1c-e: see also 
Supplementary Figure S3.1).  The responses recorded in fast and slow domains are different in both 
amplitude and temporal profile.  The amplitudes at three time points were subjected to a 2-way ANOVA 
with repeated measures: the factors were the stimulus intensity and domain type (ANOVA details in the 
figure legend).  The stimulus intensity was a significant factor at 60 (Figure 3.1c, p<0.00002), 120 (Figure 
3.1d, p < 0.00002) and 180 stimulus pulses (Figure 3.1e, p < 0.0001).  The domain type (fast and slow) 
was a significant factor at 60 and 120 stimulus pulses (Figure 3.1c, p < 0.0005; Figure 3.1d, p < 0.005) but 
not at 180 stimulus pulses (Figure 3.1e, p>0.05): this latter effect is due to the time course of the two 
profiles, as fast responses begin rapidly and slow down whereas slow responses begin slowly and speed 
up.   
The responses in Figure 3.1 exhibit overshoot, i.e. the DA signal continues to increase after the 
end of the stimulus.  The amplitude and duration of the overshoot depend on both the stimulus 
intensity and the type of domain (see Supplementary Figure S3.2).  The overshoots observed here are 
more obvious than in our previous studies (20, 23) that involved shorter stimulus durations at a stimulus 
intensity of 240 or 270 μA.  The less obvious overshoot associated with milder stimulus conditions is 
consistent with the dependence of the overshoot on the magnitude of evoked release observed here 
(Supplementary Figure S3.2).  
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Figure 3.1:  Effect of stimulus intensity on fast and slow domains: 180 pulse stimulation. 
The intensity of a 180-pulse stimulation significantly affects the average evoked DA overflow in the fast 
(a) and slow (b) domains of n=5 and n=8 individual rats respectively.  The average (± SEM) DA amplitude 
after 60 (c) and 120 (d) stimulus pulses is significantly different between fast and slow domains, but not 
at maximum amplitude (e). (2-way ANOVA with repeated measures:  stimulation intensity F(1.1,11.9) 
= 44.758, p < 0.00002, domain (fast vs. slow) F (1.1,11.9) = 28.818, p < 0.0005, interactions F(1,11) = 
10.956, p < 0.02; § stimulation intensity F(1.1,12.5) = 43.122, p < 0.00002, domain F (1,11) = 15.267, p < 
0.005; † stimulation intensity F(1.2,13.5) = 27.614 , p < 0.0001). 
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At stimulus intensities ≥250 μA the responses in both fast and slow domains exhibit a constant 
rate of linear DA clearance after the stimulus ends (Figure 3.1a,b), indicating that the extracellular DA  
concentration is sufficient to saturate the dopamine transporter (DAT).  When the DAT is saturated, the 
slope of the linear clearance profile is the apparent Vmax of DA uptake (Wightman et al., 1988a, Wu et al. 
2001b, Moquin and Michael, 2011) .  The apparent Vmax in fast domains, 3.91 ± 0.40 μM/s, is significantly 
larger than in slow domains, 2.46 ± 0.14 μM/s (t-test of independent samples: p < 0.0002).   
 The results in Figure 3.1 (and Supplementary Figures  S3.1 and S3.2) extend our prior studies, 
which were conducted at a single stimulus intensity (Moquin and Michael, 2009, Taylor et al., 2012), by 
demonstrating that objectively identified domains exhibit distinct rates of evoked DA release and 
clearance (apparent Vmax) over a broad range of stimulus intensities.  This confirms that domain-
dependent responses are not restricted to a narrow set of stimulus parameters and (vide infra) 
establishes a starting point for a more detailed examination of the properties of the domains 
themselves. 
3.3.2:  Domain-dependent effects of stimulus intensity: 60 Hz, 12 pulses 
Brief stimuli (12 pulses, 150-450 μA, 60 Hz) evoke robust DA responses in fast (Figure 3.2a) but not slow 
(Figure 3.2b) domains (the lines in Figure 3.2 are the average of responses recorded at the same sites 
used to obtain Figure 3.1, error bars are reported in Figure 3.2c).  In fast domains the stimulus intensity 
significantly affects the response amplitude (Figure 3.2c: 1-way ANOVA with repeated measures, details 
provided in the figure legend).  The expanded time scale of Figure 2 shows the details of DA release 
when the stimulus begins.  In fast domains (Figure 3.2a) DA release is detected during the first FSCV scan 
performed 100 ms (6 stimulus pulses) after the stimulus begins.  There is little or no delay in DA 
clearance at stimulus intensities ≤250 μA but a 100 ms delay appears at intensities ≥300 μA (the 
clearance delay is discussed in the section below entitled Response Overshoot).  In slow domains (Figure  
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Figure 3.2:  Effect of stimulus intensity on fast and slow domains: 12 pulse stimulation. 
12-pulse stimulation reveals the difference between fast and slow domains.  Evoked DA overflow is 
observed the fast domain (a) following each stimulus intensity ranging from 150-450 μA, whereas DA is 
only present in the slow domain (b) during 350 and 450 μA 12-pulse stimulations.  The average (± SEM) 
maximum DA amplitude (c) is significantly increased by stimulus intensity in the fast domain. (1-way 
ANOVA with repeated measures:  stimulation intensity F(1.1,4.6) = 11.972 , p < 0.05).  The solid 
symbols mark the beginning (square) and ending (triangle) each stimulus. 
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3.2b) the brief stimuli evoked no quantifiable responses at intensities below 350 μA: higher intensities 
evoked delayed responses with small amplitudes.  Under the conditions of this experiment, Figure 3.2 
show that any contribution to the slow domain response derived from diffusion of DA from the fast 
domain is minimal.  
3.3.3:  Domain-dependent effects of stimulus frequency: 250 μA, 180 pulses 
Varying the stimulus frequency (15-60 Hz, 180 stimulus pulses, 250 μA) has domain-dependent effects 
on evoked responses (the solid lines in Figures  3.3a-b are the average responses with error bars omitted 
for clarity: see also Supplementary Figure S3.3).   Responses were non-detectable at 15 Hz.  The stimulus 
frequency significantly affected the response amplitude (Figure 3.3c, p < 0.000001, 2-way ANOVA with 
repeated measures, details provided in the figure legend, 15 Hz data omitted from the ANOVA).  
Although the domain type was not a significant factor, both the 30 and 45 Hz stimuli evoked larger 
maximum amplitudes in the slow domains (the difference at 30 Hz was significant, t-test of independent 
samples, p<0.05).   As far as we are aware, this amplitude reversal (i.e. sites exhibiting larger amplitude 
at 60 Hz exhibiting lower amplitudes at 45 and 30 Hz) has not been described before.  Even so, the 
observed dependence of the amplitude on stimulus frequency is consistent with the difference in DA 
clearance from fast and slow domains (Moquin and Michael, 2011, Taylor et al., 2012) (see discussion of 
the apparent Vmax values in Figure 3.1, above).  Lower stimulus frequencies provide more time between 
the stimulus pulses for DA clearance, so the response amplitude decreases with frequency.  However, 
the amplitude decreases more rapidly in the fast domain because DA clearance is faster there.  So, this is 
the first report showing that the amplitudes of fast and slow responses exhibit a differential dependence 
on stimulus frequency. 
 The responses recorded at 30 and 45 Hz show no sign of DA diffusing from fast to slow 
domains.  First, the responses show that DA is more rapidly cleared from the fast domains (see previous  
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Figure 3.3:  Effect of stimulus frequency on fast and slow domains: 180 pulse stimulation. 
Fast (a) and slow (b) domains are significantly altered by the frequency of the stimulus (2-way ANOVA 
with repeated measures:  stimulation frequency F(1.4,15.3) = 38.022 , p < 0.000001).  180-pulse 
stimulation lasts for 12 s at 15 Hz, 6 s at 30 Hz, 4 s at 45 Hz and 3 s at 60 Hz.  30 Hz stimulation produces 
significantly higher maximum evoked DA overflow (c) in the slow domain (t-test of independent 
samples: § p < 0.05).  
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paragraph), in which case it is not available to diffuse to the slow domains.  Second, since the evoked 
concentration is higher in the slow domains (see also Supplementary Figure S3.3 for a direct 
comparison), there is no concentration gradient to drive diffusion from fast to slow domains.  So, under 
the conditions of this experiment, diffusion of DA from fast to slow domains is not evident.   
3.3.4:  Diffusion after uptake inhibition 
Uptake inhibition prolongs DA’s lifetime in the extracellular space (Church et al., 1987, Floresco et al., 
2003, Cragg and Rice, 2004, Taylor et al., 2012).  Thus, an important question is whether or not uptake 
inhibition also increases DA’s diffusion distance.  Without uptake inhibition, evoked DA in slow domains 
is barely detectable during 200 ms stimuli (Figure 3.2b).  However, robust responses are detected in fast 
and slow domains after rats are treated with nomifensine, a DA uptake inhibitor (Taylor et al., 2012).  
Nevertheless, our previous results did not indicate diffusion between the fast and slow domains.  The 
temporal profiles of the fast and slow responses after nomifensine administration were identical (see 
Figure 2.9 in chapter 2.0 of this document).  If the slow domain response were due to diffusion, then it 
should have risen slower, peaked later and lasted longer than the fast domain response: these features 
were not observed.  Thus, we are interested now to investigate further whether uptake inhibition 
promotes diffusion of DA between fast and slow domains. 
We have extended this line of investigation by modulating evoked DA release with a D2 receptor 
antagonist, raclopride (2 mg/kg i.p.) and a D2 receptor agonist, quinpirole (1 mg/kg i.p.) (Moquin and 
Michael, 2009, Wang et al., 2010), in nomifensine-treated rats.  In fast domains (Figure 3.4a), raclopride 
significantly (p < 0.05) increased (Figure 3.4c), while quinpirole significantly (p < 0.005) decreased (Figure 
3.4c), the response amplitude (ANOVA details provided in the figure legend).  In slow domains (Figure 
3.4b), evoked DA responses were barely detectable after vehicle (PBS) or quinpirole administration (the 
post-nomifensine responses in Figure 3.4 are smaller than in Figure 2.9 of chapter 2.0 of this document  
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Figure 3.4:  Effect of D2 targeting drugs during competitive DAT inhibition. 
D2 targeting drugs alter the average amplitude of the nomifensine induced DA overshoot in fast (a) and 
slow (b) domains.  In the fast domain, raclopride (n = 5) significantly increases the amplitude of DA 
overshoot (c), and quinpirole (n = 6) significantly decreases the amplitude of DA overshoot compared to 
PBS (n = 5) control.  In the slow domain, raclopride (n =6) significantly increases the overshoot duration, 
while quinpirole (n = 6) has no significant effect compared to PBS (n = 6) control.  The D2 induced 
changes in DA amplitude do not significantly alter the duration (d) of the nomifensine induced 
overshoot. (t-test of independent samples:  p < 0.05, § p < 0.005, † p < 0.0005).  
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due to the extra 30 min interval after the vehicle injection).  Even though DA in the fast domains was 
elevated for ~6-7 s (Figure 3.4a, red and green), diffusion of DA to the slow domains was not detected 
(Figure 3.4b, red and green).  Raclopride significantly (p < 0.0005) increased the response amplitude in 
the slow domain without an initial delay (Figure 3.4b, blue), confirming the presence of autoinhibited DA 
terminals in slow domains.  Figure 3.4 confirms that even after uptake inhibition voltammetry records 
the DA concentration in the immediate proximity of the recording electrode but does not “pick up” DA 
diffusing between domains.   
3.3.5:  Response overshoot 
The responses in Figures 3.1-4 exhibit overshoot, i.e. the DA signal continues to increase after the 
stimulus ends (see also Supplementary Figures 3.1-3).  Overshoot is usually attributed to a diffusion gap 
between the recording electrode and DA terminals but our results show that this cannot be so. The 
amplitude and duration of overshoot is highly sensitive to the magnitude of DA overflow, i.e. the net 
rate of DA release and clearance.  There is a systematic increase in overshoot duration and amplitude, in 
both domains, with increasing stimulus intensity (Supplementary Figure S3.2).  Likewise, overshoot 
increases with stimulus frequency (Figure 3.3 and Supplementary Figure S3.3) and after uptake 
inhibition (Figure 3.4 and chapter 2.0 of this document), both of which increase DA overflow.  Finally, 
our results show that all recording sites exhibit overshoot if overflow is high enough.  If overshoot were 
due to a physical diffusion gap, then over flow would be a permanent feature of the responses recorded 
at any given site: it would not be sensitive to the stimulus or pharmacological conditions.  
Inspection of our results shows that overshoot is strongly impacted by DAT kinetics.  Overshoot 
is smaller in fast domains compared to slow domains (Supplementary Figure S3.2), which coincides with 
the larger apparent Vmax of clearance in the fast domains (above) and is largest after uptake inhibition 
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(Figure 3.4).  Thus, we report here for the first time that overshoot is a function of DAT kinetics rather 
than a diffusion gap.  
3.3.6:  DA diffusion after uptake inhibition: low frequency stimulation 
In slow domains, evoked DA release is non- or barely detectable at stimulus frequencies of 15 or 
30 Hz, respectively (250 µA, 180 stimulus pulses, Figure 3.5a,b).  This might be because uptake prevents 
DA from reaching the electrode.  However, there is an obvious problem with this explanation because 
the intervals between the 15 and 30 Hz stimulus pulses (67 and 33 ms, respectively) are substantially 
less than the time needed for DA clearance.  For example, under mild stimulus conditions, pseudo-first 
order DA clearance from slow domains requires several seconds (e.g. Figure 3.1b, 200-300 μA).  In that 
case, complete DA clearance in 67 ms should not be possible.  So, there is a timing mismatch between 
these observations.   
Nomifensine (20 mg/kg i.p.) dramatically increased the response amplitude in slow domains at 
15 and 30 Hz (Figure 3.5a,b: solid lines are the averages from n=4 rats and dashed lines are the 
confidence intervals based on the SEM).  The first 1.5 s of the responses are displayed on an expanded 
scale in Figures  3.5c and 3.5d to emphasize that nomifensine did not abolish the initial delay in evoked 
release.  At 15 Hz, the DA signal increased significantly 1.3 s after the stimulus began (t-test of paired 
samples, p < 0.05 compared to pre drug response), i.e. after 19 stimulus pulses.  At 30 Hz, the DA signal 
reached significance 600 ms after the stimulus began (t-test of paired samples, p < 0.05 compared to pre 
drug response), i.e. after 18 stimulus pulses.  Thus, regardless of the stimulus frequency, the same 
number of stimulus pulses, i.e. the same amount of DA release, was required before the DA signal 
appeared at the electrode. 
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Figure 3.5:  Effect of nomifensine during low frequency stimulation. 
Nomifensine increases the average (± SEM) evoked DA overflow in the slow domain in response to low 
frequency 15 (a) and 30 Hz (b) stimulations in n = 4 rats.  After treatment with nomifensine, DA arrives 
after 1.3 s of 15 Hz (c, enlargement of the dashed box in (a)) stimulation (vertical dashed line, 19 
stimulus pulses) and after 0.6 s of 30 Hz (d, enlargement of the dashed box in (b)) stimulation (vertical 
dashed line, 18 stimulus pulses). 
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3.3.7:   Restricted diffusion of DA in the extracellular space of the rat striatum 
In a previous report (Taylor et al., 2012), we suggested that Nicholson’s model of restricted diffusion 
(Hrabetova et al., 2003, Hrabetova and Nicholson, 2004, Tao et al., 2005, Sykova and Nicholson, 2008) 
explained several unexpected features of evoked DA responses in the dorsal striatum.  This same 
mechanism explains the new findings of the present study.   A major new finding is that DA’s ability to 
diffuse between fast and slow domains is severely limited.  Obviously, DA diffuses between DA terminals 
and the recording electrode in both domains: DA would not be detected otherwise.  But, we find no 
clear evidence that DA makes its way from the fast domains to the slow domains under any conditions 
we have examined.  The simplest explanation for this observation is that pathways through the 
extracellular space are obstructed, as described by Nicholson and coworkers(Hrabetova et al., 2003, 
Hrabetova and Nicholson, 2004, Tao et al., 2005, Sykova and Nicholson, 2008). 
A second new finding is the dependence of DA overshoot on the magnitude of evoked overflow.  
Our working hypothesis is that restricted diffusion causes DA to be “held up” in the extracellular space 
and then either make its way to the electrode or return to DA terminals according to the balance 
between the rate of release and clearance.  Thus, there is less overshoot if release is small (mild 
stimulation conditions) or if uptake is more efficient (DA is cleared faster in the fast domain than from 
the slow domain (Moquin and Michael, 2011)).  There is more overshoot if uptake cannot efficiently 
remove DA from the extracellular space, allowing more DA to “leak” over to the electrode.  This happens 
when release is large (longer, more intense, or higher frequency stimulation) or when uptake is slowed 
(observed in the slow domain or following uptake inhibition).   
A third major finding is in regards to the response to low frequency stimulation (15 Hz, Figure 
3.5).  The absence of a detectable response highlights the timing mismatch issue explained above.  
Again, our working hypothesis is that DA is “held up” in the extracellular space but in this case, because 
the stimulus frequency is so low, there is not enough DA to overcome the capacity of the restrictions 
64 
 
upon diffusion and DA is cleared by DAT without “leaking” over to the electrode.  Thus, restricted 
diffusion accounts for the timing mismatch in these low-frequency responses. 
 
3.4:  CONCLUSIONS 
Numerous investigators, ourselves included, have long adopted a by-now conventional model to 
describe DA’s diffusion in the extracellular space.  In the conventional model, the diffusion coefficient is 
affected by tissue tortuosity and the DA’s lifetime for diffusion is constrained by DA uptake.  While the 
conventional model aptly describes some evoked responses, it does not capture the several new 
features of the domain-dependent responses recorded from the dorsal striatum.  A central conclusion 
stemming from this finding is that restricted diffusion, the subject of in-depth investigations by 
Nicholson and coworkers (Hrabetova et al., 2003, Hrabetova and Nicholson, 2004, Tao et al., 2005, 
Sykova and Nicholson, 2008), plays a dominant role in determining DA’s spatiotemporal dynamics in the 
extracellular space.  Thus, we conclude that restricted diffusion enables DA terminal field to maintain a 
domain-dependent autoinhibitory tone, a demonstrated feature of the dorsal striatum’s domain 
patchwork.  
 
3.5:  SUPPLEMENTARY INFORMATION 
Supplementary Figure S3.1 contains the same data as Figure 3.1 of the main text presented in a different 
format to aide comparison of the domain-dependent evoked responses at each current intensity (150-
450 μA, 60 Hz, 3 s).  The solid lines are the average of multiple responses recorded in multiple rats in 
objectively identified fast (red, n=5) and slow (blue, n=8) domains: the dashed lines are confidence 
intervals based on standard errors: the solid symbols mark the beginning (square) and ending (triangle) 
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each stimulus.  The previously-identified (Moquin and Michael, 2009, Moquin and Michael, 2011, Taylor 
et al., 2012) hallmark features of responses recorded in fast domains include (i) immediate DA release 
when the stimulus begins, (ii) short-term depression with the rate of evoked response decreasing as the 
stimulus proceeds (except at the lowest stimulus intensity, 150 μA) and (iii) rapid DA clearance 
compared to the slow domains (based on the apparent Vmax, see main text).  Responses in slow domains 
exhibit (i) an initial delay in the onset of DA release when the stimulus begins, (ii) short term facilitation 
with the rate of evoked response increasing as the stimulus proceeds and (iii) slow DA clearance 
compared to the fast domains.   
Supplementary Figure S3.2 summarizes the duration (a) and amplitude (b) (mean ± SEM) of the 
overshoots observed at the end of 3-s stimuli over a range of stimulus intensities (the responses 
themselves are contained in Figure 3.1 of the main text and Supplementary Fig. S3.1).  Both the duration 
and amplitude of the response overshoots increase significantly with stimulation intensity (2-way 
ANOVA with repeated measures:  stimulation intensity F(1,4) = 6.640, p < 0.0005; § stimulation 
intensity F(1,4) = 5.842, p < 0.0002).  At the higher stimulation intensities of 350 and 450 µA, the 
overshoot duration is significantly larger in the slow domains compared to the fast domains († post hoc 
tukey test comparison, p < 0.05).  Responses reported in our previous studies of fast and slow domains 
contain relatively little evidence of overshoot, except after uptake inhibition.  However, those studies 
mainly involved shorter stimulus durations at a stimulus intensity of 240 or 270 μA: such stimulus 
conditions keep DA overflow at a relatively low magnitude, which explains why overshoot was less 
apparent.   
Supplementary Figure S3.3 contains the same data as Figure 3.3 of the main text but in a 
different format designed to aid comparison of the responses recorded in fast and slow domains at 30 
(a) and 45 Hz (b).  The response in slow domains at 30 Hz is highly asymmetric, exhibiting an initial delay 
of 2-3 s but a much shorter delay with the stimulus ends.  The conventional model of evoked responses 
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does not predict these asymmetric delays when the stimulus begins and ends (Taylor et al., 2012).  
Likewise, the conventional model does not predict that the delays should be affected by the stimulus 
conditions.  
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Supplementary Figure S3.1:  Comparative effects of stimulus intensity on fast and slow domains. 
This rerepresentation of Figure 3.1 comparatively shows that average (±SEM) fast (red) and slow (blue) 
domains exhibit domain dependent responses to 3 second MFB stimulations of varying current intensity.  
The beginning of stimulation is denoted by the square and the end of stimulation is denoted by the 
triangle.   
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Supplementary Figure S3.2:  Effect of stimulus intensity of DA overshoot. 
Both the duration and amplitude of the response overshoots observed in Figure 3.1 of the main text 
increase significantly with stimulation intensity (2-way ANOVA with repeated measures:  stimulation 
intensity F(1,4) = 6.640, p < 0.0005; § stimulation intensity F(1,4) = 5.842, p < 0.0002).  At the higher 
stimulation intensities of 350 and 450 µA, the overshoot duration is significantly larger in the slow 
domains compared to the fast domains († post hoc tukey test comparison, p < 0.05).   
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Supplementary Figure S3.3:  Comparative effect of stimulus frequency on fast and slow domains. 
This rerepresentation of Figure 3.3 comparatively shows that average (±SEM) fast (red) and slow (blue) 
domains exhibit domain dependent responses to 3 second MFB stimulations of varying stimulation 
frequency.  In both the 30 and 45 Hz stimulations, the slow domain produces a higher amplitude of 
evoked DA overflow than the fast domain.  The beginning of stimulation is denoted by the square and 
the end of stimulation is denoted by the triangle.   
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4.0:  FIVE DA DOMAINS IN THE DORSAL STRIATUM: INSIGHT ON DA CLEARANCE 
 
 
 
4.1:  INTRODUCTION 
Dopamine (DA) is an important neurotransmitter involved in the signaling pathway for a variety of 
physiological functionality including motor control, sexual arousal and reward (Hull et al., 1999, Brooks, 
2001, Urban et al., 2012).  Its dysfunction is associated with numerous devastating disorders, such as 
Parkinson’s disease, Alzheimer’s, and schizophrenia (Pappata et al., 2008, de la Fuente-Fernandez et al., 
2011, Kim et al., 2011).  Furthermore, it has been shown that DA signaling on multiple time scales is 
responsible for this varied functionality (Grace, 1991, Schultz, 2007).  Because of this time dependence, 
it is important to understand the rapid kinetics of DA signaling in vivo.  Fast scan cyclic voltammetry 
(FSCV) at carbon fiber microelectrodes (CFE) paired with medial forebrain bundle (MFB) stimulated DA 
release affords the high spatial and temporal resolution necessary to study DA kinetics (Michael and 
Wightman, 1999). 
Previous studies have revealed the existence of two spatially discrete DA domains in the rat 
dorsal striatum, termed the fast and slow domains (Moquin and Michael, 2009, Wang et al., 2010, 
Moquin and Michael, 2011, Taylor et al., 2012, Taylor et al., 2013).  The fast domain was identified as a 
location where the ascending phase of the evoked DA signal begins to rise immediately upon the onset 
of MFB stimulation and the response exhibited short term depression upon further stimulation.  The 
slow domain was described as a location where initial DA release inhibited upon the start of MFB 
stimulation and the profile exhibits short term facilitation upon continued stimulation.  It was believed 
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that the evoked DA response from the fast domain was short lived (< 500 ms) due to the short term 
inhibition caused by the onset of autoinhibition in the fast domain (Moquin and Michael, 2009).  
Furthermore, prolonged stimulation allows for the co-detection of neighboring slow domains, yielding a 
hybrid response (Wang et al., 2010).  Because of this, many studies comparing fast and slow domains 
restrict the stimulus duration (200 ms, 60 Hz) in order to exclude the slow domain contribution (Moquin 
and Michael, 2009, Moquin and Michael, 2011, Taylor et al., 2012).  While this may be the case in 
certain instances, further examination of the effect of prolonged stimulation on the fast domain show 
the existence of four kinetically discrete sub-domains in the dorsal striatum. 
 
4.2:  MATERIALS AND METHODS 
4.2.1:  Carbon fiber microelectrodes 
A single carbon fiber (7-µm diameter, T650; Cytec Carbon Fibers LLC., Piedmont, SC, USA) was aspirated 
through a borosilicate capillary (0.4 mm ID, 0.6 mm OD; A-M systems Inc., Sequim, WA, USA) and then 
pulled to a fine tip using vertical puller (Narishige, Los Angeles, CA, USA).  The carbon fiber was 
immobilized by sealing the tip with low viscosity epoxy (Spurr Epoxy; Polysciences Inc., Warrington, PA, 
USA), and the exposed portion of the fiber was trimmed to a final length of 200 µm.  Electrical 
connection was made using a drop of mercury and a nichrome hookup wire (annealed nichrome wire; 
Goodfellow, Oakdale, PA, USA).  Electrodes were bathed in isopropyl alcohol for at least 15 minutes 
prior to use (Bath et al., 2000). 
4.2.2:  Fast scan cyclic voltammetry 
Fast scan cyclic voltammetry was performed using either an EI-400 (Ensman Instruments, Bloomington, 
IN) or a custom-built potentiostat (Electronics Shop, Department of Chemistry, University of Pittsburgh) 
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and a Keithly 428 current amplifier (Keithley Instruments, Cleveland, OH, USA) controlled by ‘CV Tar 
Heels v4.3’ software (courtesy of Dr. Michael Heien, University of Arizona, Tucson, AZ, USA).  The 
reference electrode was Ag/AgCl.  The applied potential waveform linearly swept at 400 V/s from a 
resting potential of 0 V vs. Ag/AgCl to +1.0 V, then to -0.5 V and then back to 0 V at a frequency of 10 Hz.  
DA was identified via inspection of background-subtracted cyclic voltammograms and was quantified 
using the oxidation currents recorded between 0.5 and 0.7 V on the initial ramp. 
4.2.3:  Electrode calibration 
Electrodes were calibrated in a flow cell using freshly prepared, nitrogen-purged, dopamine HCl (Sigma 
Aldrich, St. Louis, MO, USA) standard solutions dissolved in artificial cerebrospinal fluid (144 mM Na+, 1.2 
mM Ca2+, 2.7 mM K+, 1.0 mM Mg2+, 149.1 mM Cl-, and 2.0 mM phosphate, pH 7.4).  In vivo DA 
concentrations were determined by post calibration results. 
4.2.4:  Animals 
All work involving the use and care of animals was approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee.  Male Srague-Dawley rats (250-350 g, Hilltop Labs, Scottsdale, PA, 
USA) were intubated and anesthetized with isoflurane (2.5% by volume) prior to being placed in a 
stereotaxic frame with the incisor bar raised to 5 mm above the interaural line (Pellegrino et al., 1979).  
Internal body temperature was maintained at 37˚C using a heating blanket (Harvard Apparatus, 
Holliston, MA, USA).  After removing the scalp, three holes were drilled into the skull for the purpose of 
electrode implantation.  The CFE was implanted in the dorsal striatum (2.5 mm anterior to bregma, 2.5 
mm lateral from bregma and 5 mm below the cortical surface: the final vertical placement was 
optimized so that the electrode was positioned in either the fast or the slow domain (Moquin and 
Michael, 2009, Moquin and Michael, 2011, Taylor et al., 2012, Taylor et al., 2013)).  Electrical contact 
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between brain tissue and a reference electrode was via a salt bridge.  The stimulating electrode (bipolar 
stainless steel, MS303/a; Plastics One, Roanoke, VA, USA) was positioned over the MFB (2.2 mm 
posterior to bregma, 1.6 mm lateral from bregma and 7-8.5 mm below the cortical surface: the final 
vertical placement was optimized to evoke maximal DA release in the ipsilateral striatum (Ewing et al., 
1983, Kuhr et al., 1984, Stamford et al., 1988)).  The MFB was stimulated for 3 seconds using an optically 
isolated stimulus waveform (Neurolog 800, Digitimer, Letchworth Garden City, U.K.) of a biphasic, 
constant-current, square wave (4 ms per pulse, 250 μA pulse height and 60Hz frequency).  
4.2.5:  Data analysis 
The kinetic profiles of each response were assessed by comparing the amplitude of the evoked DA 
overflow every 500 ms during the 3 second stimulation.  Linear clearance rates were measured as the 
slope of the descending phase of the response where at least five data points produce an r2>0.99.  
Statistical analysis within and between groups were completed using either one-way ANOVA or two-way 
ANOVA with a repeated measures design (SPSS software).  Average color plots were produced using 
MATLAB.  The false color distribution was optimized for each trace to provide detailed information of 
any small amplitude changes.  Clearance profiles were modeled using a model of first order clearance 
adjusted with the addition of a constant efflux term as well as with Michaelis-Menten uptake kinetics 
(Wightman et al., 1988a, Wu et al., 2001b) using a fixed KM value of 0.2 µM (Near et al., 1988, Wu et al., 
2001b) and Vmax values determined by the individual curves. 
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4.3:  RESULTS 
4.3.1:  Identification of fast and slow domains 
Fast and slow domains were initially identified using the well documented procedure of optimizing the 
CFE position through incremental 50-100 µm dorsal-ventral (DV) adjustments (Moquin and Michael, 
2009, Moquin and Michael, 2011, Taylor et al., 2012, Taylor et al., 2013).  Once either a fast or slow 
domain was obtained, the response to a 3 second 60 Hz stimulation was collected.  The carbon fiber was 
lowered along a single DV track located at the coordinates described in the methods section.  To ensure 
that the recording location remained within the dorsal striatum, DV lowering was limited to no more 
than 1 mm.  Multiple penetrations were not conducted. 
4.3.2:  Four kinetic sub domains of the fast domain in the dorsal striatum 
The fast domain of the dorsal striatum is composed of four unique kinetic sub domains, termed Fast 
Types 1-4 (average traces ± SEM displayed in Figure 4.1).  Each sub domain is objectively identified 
based on fixed criteria describing the kinetic profile of the ascending portion of the evoked DA overflow 
curve.  Type 1 responses are defined as those where the rising edge is linear during the entire duration 
of a 3 second stimulation.  They are objectively identified as locations where the slope of the rising edge 
exhibits an r2>0.99.  Type 2 responses are linear for the majority of a 3 second stimulation, but exhibit 
short term depression during the latter portion of the stimulus.  These are objectively identified as 
responses where the slope of the rising edge exhibits an r2<0.99 and the evoked DA overflow increases 
for the entire duration of the stimulation.  Type 3 responses are defined as those that initially rise upon 
the onset of stimulation, but quickly exhibit short term depression to such an extent that the evoked DA 
overflow response begins to descend before the end of stimulation.  These are objectively identified as 
responses where the slope of the rising edge exhibits an r2<0.99 and the evoked DA overflow descends  
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Figure 4.1:  Four discrete sub domains of the fast domain in the dorsal striatum. 
There are four discrete fast sub domains in the rat dorsal striatum.  In n=90 individual animals, 38 were 
Type 1 (blue), 37 were Type 2 (red), 6 were Type 3 (green) and 9 were Type 4 (purple).  The average 
(±SEM) response from each sub domain to a 3 second, 60 Hz stimulation is shown above.  For this and all 
subsequent evoked DA overflow curves, the start of stimulation is denoted by the open square and the 
end of stimulation is marked by the open triangle.  
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prior to the end of stimulation.  Type 4 responses were previously termed “hybrid sites” (Moquin and 
Michael, 2009) and are defined as a response where DA increases upon the start of stimulation, 
immediately exhibits short term depression and further stimulation promotes short term facilitation.  
Type 4 profiles are objectively identified as responses where the slope of the rising edge exhibits an 
r2<0.99 and the first derivative of the rising edge of the evoked DA overflow response switches from 
negative to positive as the stimulation proceeds. 
Figure 4.1 displays the average kinetic profiles for Types 1-4 collected from 90 individual 
animals.  This large sample group provides insight to the relative distribution of each sub domain in the 
dorsal striatum.  Type 1 responses were observed in 38/90 animals, Type 2 responses were found in 
37/90 animals, Type 3 in 6/90 and Type 4 in 9/90.  This corresponds to a percent composition of 42% 
Type 1, 41% Type 2, 7% Type 3 and 10% Type 4 in the dorsal striatum.   
As shown in previous studies, comparison of maximum amplitude alone may preclude the 
identification of discrete kinetic domains (Stamford et al., 1986, May and Wightman, 1989b, Kawagoe et 
al., 1992, Taylor et al., 2013).  Instead, careful consideration must be paid to kinetic profile of the evoked 
DA overflow responses, which manifest as changes in DA concentration over time.  A convenient way to 
statistically compare kinetic domains is to plot their respective DA concentrations at various time points 
during stimulation (Taylor et al., 2013).  Figure 4.2 represents the average responses shown in Figure 4.1 
by displaying the average DA concentrations (± SEM) every 500 ms over the duration of the 3 second 
stimulation.  According to two-way ANOVA with repeated measures design, Types 1-4 are significantly 
different (p<0.005) over the duration of the stimulation.  One-way ANOVA between site types at each 
time point reveal that Types 1-4 do not significantly deviate from each other until after the first second 
of stimulation. In fact, the average (± SEM) DA concentration of all four fast sub domains entirely 
overlap 500 ms after the start of stimulation.   
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Figure 4.2:  Sub domains exhibit significantly different kinetic profiles. 
The average DA concentrations (± SEM) of the evoked DA overflow curves shown in Figure 4.1 plotted 
every 500 ms over the duration of the 3 second stimulation reveals that the four fast sub domains are 
significantly different (Two-way ANOVA with repeated reassures p<0.005).  The four sub domains 
significantly differ after one second of stimulation (One-way ANOVA p<0.02). 
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4.3.3:  Sub domain dependent linear clearance rates 
Maximum linear clearance rate is sub domain dependent.  One-way ANOVA comparison of average (± 
SEM) linear clearance rates from Types 1-4 (displayed in Figure 4.3) show that clearance rates 
significantly (p<0.05) depend on site type.  Type 1 exhibits a linear clearance rate of 6.94 ± 0.64 µM/s, 
Type 2 clears DA at 5.27 ± 0.35 µM/s, Type 3 has a rate of 3.90 ± 0.86 µM/s and Type 4 has a rate of 6.57 
± 0.81 µM/s.  This reduces to three distinct clearance rates.  Type 1 and Type 4 exhibit similar fast 
clearance kinetics, followed by slower clearance typical of Type 2 and then again by the slowest 
clearance from Type 3 sites. 
Comparison of average linear clearance rates (Figure 4.3) with average maximum DA amplitude 
(Figure 4.2, 3sec) reveals that linear clearance rate scales with maximum amplitude (with the exception 
of Type 4 sites).  In fact, Figure 4.4 shows that the comparison of linear clearance rate to maximum 
concentration for each of the 90 responses in this study produces a statistical linear correlation 
(Pearson’s correlation coefficient 0.760, 2-tailed t-test p<0.00002).  Each sub domain is displayed in 
Figure 4.4 as a different symbol.  Type 1 animals are shown as blue diamonds, Type 2 are red squares, 
Type 3 are green triangles, and Type 4 are displayed as purple X’s.  The symbols for Types 1-3 appear to 
be equally distributed around the linear regression fit, whereas the Type 4 animals lie primarily above 
the regression fit. 
4.3.4:  Selective detection of DA hang-up 
 Evoked DA overflow curves do not return to baseline for at least 8 seconds following the end of 
stimulation.  Figure 4.5 is a re representation of the data displayed in Figure 4.1 with the SEM traces 
removed for clarity.   Figure 4.5 also includes the average response from the slow domain of 78 
individual animals in response to 3 second MFB stimulation.  Slow domains do not appear to be 
composed of any discernible sub domains, thus Figure 4.5 represents a total of five discrete kinetic DA  
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Figure 4.3:  Sub domains exhibit significantly different linear clearance rates. 
Maximum linear clearance rate is sub domain dependent.  The average (± SEM) linear clearance rates of 
the evoked DA overflow responses shown in Figure 4.1 are significantly different by sub domain type 
(One-way ANOVA p<0.05).  
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Figure 4.4:  Linear correlation of between maximum amplitude and linear clearance rate. 
Maximum linear clearance rate scales linearly with the maximum total amplitude of evoked DA 
overflow.  In a plot representing all 90 animals represented in Figure 4.1 the linear clearance rate is 
significantly correlated with maximum concentration (Pearson’s correlation coefficient 0.760, 2-tailed t-
test p<0.00002).  Type 1 animals are shown as blue diamonds, Type 2 are red squares, Type 3 are green 
triangles and Type 4 are displayed as purple X’s.    
81 
 
 
 
 
Figure 4.5:  Five kinetic domains in the dorsal striatum: existence of a hang up feature. 
All five DA domains in the dorsal striatum return to an elevated steady state DA tone following the end 
of stimulation (shown by the portion of the curves enclosed in the dashed box).  Above is a 
rerepresentation of the average responses shown in Figure 4.1 (±SEM removed for clarity) with the 
addition of the average response to an identical stimulation from the slow domain (orange) of 78 
individual animals.  All five domains fail to return to baseline DA concentration established prior to the 
start of stimulation. 
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domains that exist in the dorsal striatum.  Detailed examination of the responses from approximately 
7.5-10 seconds (highlighted by the dashed box in Figure 4.5) show that all five domains reach a steady 
state condition where DA levels are elevated compared to the pre-stimulus baseline.  This lasting 
elevation will be termed the “DA hang-up”. 
The DA hang-up feature is confirmed to be solely DA in nature by examination of average false 
color plots.  Figure 4.6a represents the average false color plot for Type 1 responses (largest amplitude 
DA hang-up) and Figure 4.6b represents the average false color plot from the slow domain responses 
(smallest amplitude DA hang-up).  Both Figures 4.6a and b are oriented with time on the x-axis, applied 
potential on the y-axis and DA concentration in false color.  Evoked DA overflow traces, like those shown 
in Figure 4.1, are obtained by plotting the concentration vs time at the potential of maximum DA 
oxidation (denoted by the white dashed lines). DA concentration values can only be assigned to the DA 
oxidation peak, which initially appears in green and tapers off to red at approximately +0.7 V.  The 
characteristic DA reduction peak is shown in blue at approximately -0.2 V.  Stimulation begins at 0 
seconds and continues for 3 seconds.  In both Type 1 and slow responses, both the DA oxidation and 
reduction peaks continue out to 10 seconds.  This serves as a characteristic fingerprint for DA and 
confirms that the DA hang-up is the result of elevated DA. 
Further analysis of the average color plots show that there is an initial current fluxuation around 
+0.2 V (blue band) as well as a series of fluxuations appearing following the switching potentials (red 
band around +0.9 V and blue band around +0.3 V above the DA reduction peak).  Due to the unique 
positioning of each of these current contributions, DA quantification can be carried out without 
unwanted interference from outside current contaminants.   
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Figure 4.6:  False color plots selectively confirm the hang up feature is DA in origin. 
Average false color plots for Type 1 (a, n = 30) and slow (b, n = 30) domain responses to 3 second 60 Hz 
stimulation.  Stimulation occurs from 0-3 seconds.  Time is displayed on the x-axis, applied potential on 
the y-axis and DA concentration is in false color.  The white dashed line corresponds with the peak DA 
oxidation potential and is used for generating evoked DA overflow traces.  The DA concentration scale is 
only used to quantify DA oxidation features (green tapering to red).  Both plots exhibit the characteristic 
fingerprint of DA out to 10 seconds. 
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4.3.5:  Modeling of clearance profiles 
The average DA clearance profiles from all five domains were modeled using a first order clearance 
relationship scaled with a constant efflux term as well as with the conventional Michaelis-Menten 
uptake model (Wightman et al., 1988a, Wu et al., 2001b).  In each case the fit was set to begin at the 
point where the first derivative of the descending phase reaches its maximum to remove any effects of 
mass transport due to DA overshoot phenomena.  Figures 4.7a and b each display the average responses 
from all five domains (shown previously in Figure 4.5) in dot representation.  The solid red lines in Figure 
4.7a show the scaled first order fit for each curve created using the following relationship, d[DA]/dt = 
[DA](1-U)*dt + S*dt.  In each case, the newly proposed fit modeled the latter portion of the clearance 
profile, including the DA hang-up feature.  The U and S terms for each domain are displayed in Table 4.1.  
Figure 4.7b shows the Michaelis-Menten fit of the average responses, using a fixed KM value of 0.2 µM 
(Near et al., 1988, Wu et al., 2001b) and Vmax values determined by the maximum linear clearance rate 
for each average curve.  The Michaelis-Menten fit does not account for the DA hang-up feature and thus 
does not adequately fit the data. 
 
4.4:  DISCUSSION 
This study serves as an extension of previous work from our laboratory concerning the existence of 
discrete fast and slow kinetic domains in the dorsal striatum (Moquin and Michael, 2009, Wang et al., 
2010, Moquin and Michael, 2011, Taylor et al., 2012, Taylor et al., 2013).  We have shown that these 
spatially distributed domains are unique entities that exhibit domain dependent responses to 
pharmacological treatment.  Until recently, studies in the fast domain were limited to brief MFB  
stimulations (200 ms, 60 Hz stimuli) due to the belief that contribution from fast domains was limited 
due to the rapid onset of autoinhibition (Benoit-Marand et al., 2001, Moquin and Michael, 2009).  This  
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Figure 4.7:  Modeling of DA clearance profiles. 
Mathematical modeling of the average evoked DA overflow curves (black dots) for all five domains are 
displayed in Figure 4.5 using a scaled first order clearance model (a, red traces) and the traditional 
Michaelis-Menten uptake model (b, orange traces) with a fixed Km of 0.2 µM.  The parameters for each 
fit are displayed in Table 4.1. 
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Table 4.1:  Modeling parameters used for the fits in shown in Figure 4.7. 
Parameters for the mathematical models of each average evoked DA overflow response displayed in 
Figure 4.7.  The U and S terms correspond to the scaled first order fit in Figure 4.7a and the Vmax and KM 
terms were used for the Michaelis-Menten model shown in Figure 4.7b.  KM was fixed to 0.2 µM in 
accordance to the literature (Near et al., 1988, Wu et al., 2001b). 
 
 
  
 U (s-1) S (s-1) Vmax (µM/s) KM (µM) 
Type 1 0.73 0.089 5 0.2 
Type 2 0.65 0.06 4 0.2 
Type 3 1.05 0.092 3 0.2 
Type 4 1.2 0.12 6 0.2 
Slow 0.91 0.065 2.5 0.2 
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study shows that while that may be the case in some instances (e.g. Type 4 response), the majority of 
fast domain exhibits a robust response to continued stimulation.   
4.4.1:  Evaluating discrete DA kinetic domains 
The dorsal striatum is composed of five discrete DA kinetic domains (shown in Figure 4.5): the previously 
described slow domain (Moquin and Michael, 2009) and the newly discovered four sub domains of the 
fast domain (Types 1-4).  The four fast sub domains do not significantly deviate from each other until the 
duration of a 60 Hz stimulation exceeds one second.  This explains the omission of the Type 1-4 sub 
domains in previous studies where the stimulation duration in the fast domain was limited to 200 ms.  
While we acknowledge that the 3 second 60 Hz MFB stimulations needed to reveal the differences 
between these sub domains is super-physiological, the information provided by such stimulations is 
quite relevant. 
The large sample group used in this study allows us to draw conclusions as to the relative 
distribution of the Type 1-4 domains.  Domains Type 1 and 2 are by far the most common of the fast sub 
domains, combining together to compose 83% of the total responses.  This is not surprising, due to the 
prevalence of Type 1 and Type 2 responses in the literature (Stamford et al., 1986, Wightman et al., 
1988a, May and Wightman, 1989a, Kawagoe et al., 1992, Wu et al., 2001b, Wu et al., 2002, Greco et al., 
2006, Taylor et al., 2013).  They are followed by 10% Type 4 and 7% Type 3.  While these lesser observed 
responses have appeared in the literature (Kawagoe et al., 1992, Garris and Wightman, 1995, Garris et 
al., 1997, Venton et al., 2006, Moquin and Michael, 2009), they are far outnumbered by the previous 
two.  This is likely due to CFE optimization via repositioning (Kawagoe et al., 1992, Jones et al., 1995a, 
Greco and Garris, 2003, Venton et al., 2003).  Optimization is a commonly practiced procedure that 
takes into account that DA kinetic domains are spatially discrete regions (Taylor et al., 2013) to position 
the CFE in a location yielding maximum DA amplitude.  This practice was first introduced because of the 
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belief that any feature inconsistent with a Type 1 or 2 responses was the result of a diffusional distortion 
caused by a physical gap between the DA release terminals and the CFE detector (Kawagoe et al., 1992, 
Venton et al., 2003).  As a result of this belief, many of the published evoked DA overflow responses 
have been subjected to a mathematical deconvolution algorithm to account for those unwanted 
features of the data (Kawagoe et al., 1992, Jones et al., 1995a, Wu et al., 2001b).  Our laboratory has 
shown in this and in previous studies that those features are in fact physiological (Moquin and Michael, 
2009, Wang et al., 2010, Moquin and Michael, 2011, Taylor et al., 2012, Taylor et al., 2013) in origin and 
should not be subjected to any mathematical manipulation. Due to CFE optimization and deconvolution, 
previous studies have unknowingly extensively optimized for Type 1 and 2 domains, thus describing only 
a portion of the entire DA terminal field. 
The existence of five discrete DA domains is not surprising based on the multiple functionality of 
DA (Hull et al., 1999, Brooks, 2001, Obeso et al., 2008, Urban et al., 2012) and the known multiple time 
courses of DA signaling (Schultz, 2007).  Although we have yet to conduct any behavioral studies 
concerning DA domains, we hypothesize that such a varied functionality could require several 
mechanisms of DA signaling. 
4.4.2:  Multiple linear clearance rates 
Linear clearance rate is sub domain dependent.  Classic DA modeling describes evoked DA overflow in a 
specific brain region as a balance of release and Michaelis-Menten governed uptake described by single 
KM and Vmax values (Wightman et al., 1988a, Wu et al., 2001b).  Vmax is described as the maximum linear 
rate of DA uptake into the dopamine transporter (DAT).  Furthermore, the apparent Vmax value 
measured by electrochemical sensors depends on the DAT density surrounding the probe (Stamford et 
al., 1986, Wightman et al., 1988a).   The domain dependence of linear clearance rate is in direct conflict 
with the idea of a single Vmax value governing the dorsal striatum.  In addition, the statistical correlation 
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of linear clearance rate to maximum DA amplitude suggests that DA clearance is better described using 
a first order relationship instead of Michaelis-Menten kinetics.  This correlation between linear 
clearance rate and maximum DA amplitude was previously shown by Stamford et al. (1986) to support 
the idea of a single Vmax value.  In that study, Stamford suggested that the reasoning underlying the 
relationship was due to a mutual increase in DA releasing sites and DAT, thus increasing both terms in a 
fixed proportion.  While this may be the case, further consideration of other possible clearance 
mechanisms is still justified. 
4.4.3:  Benefits afforded from signal averaging: Selective DA detection 
Effective analytical detection is dependent on the sensitivity, selectivity and limits of detection of the 
detector (Harris, 2003).  In vivo electrochemical detection of DA at CFEs exhibit high spatial and 
temporal resolution, high sensitivity and a LOD of approximately 200 nM.  An issue that commonly 
arises with electrochemical detection methods is analyte selectivity.  Chronoamperometry provides 
unparalleled temporal resolution, but is unable to discern between analytes.  FSCV provides a 
moderately higher selectivity, but is still unable to separate any analytes exhibiting the same redox 
potentials.  Therefore, it is of utmost importance to account for any possible interferences during the 
analysis of electrochemical detection (Michael and Wightman, 1999).  Many recent studies have been 
published describing the use of Principle Component Analysis (PCA) to extract the contributions of 
individual analytes, such as pH and O2, from an in vivo FSCV recording (Phillips et al., 2003, Heien et al., 
2004, Heien et al., 2005).  While much work has been published justifying PCA data manipulation, great 
care must still be made to not unintentionally remove chemically relevant features.  Detailed analysis of 
electrochemical data can be complicated by a poor signal to noise ratio.  In this study, we make us of the 
fact that signal and noise are uncorrelated.  Signal strength is constant during repeated measurements, 
whereas noise is random.  Therefore signal averaging will decrease the random noise, thus increasing 
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the affective signal to noise ratio of the measurement.  This allows for detailed data interpretation of 
small amplitude phenomena typically masked by noise interferents. 
The average false color plots of Type 1 and slow domain responses (Figure 4.6) show the 
selectivity of our detection for DA.  Neither Figure 4.6a or b show any feature attributable to pH or any 
other interferent presenting at the potential of DA oxidation.  The only non-DAergic current fluxuations 
observed in the color plots appear initially at approximately +0.2 V and following the switching 
potentials, features typical of a capacitive change (Takmakov et al., 2010).  These fluxuations are 
triggered by the onset of MFB stimulation, suggesting that they are action potential mediated.  While 
many factors can affect the double layer leading to a change in capacitive current, it is likely that the 
action potential mediated cation flux (e.g. Ca2+, K+, Na+) leads to the current fluxuation.  Regardless of 
the source of the non-DAergic fluxuation, the important factor is that the current does not appear at the 
maximum potential of DA oxidation used for DA quantification.  Therefore, our detection method is 
highly selective for DA and requires no PCA data manipulation.  Any PCA manipulation would only risk 
distorting the DA signal. 
4.4.4:  Long term DA hang-up 
The lowered affective LOD afforded by the color plot averaging allows for the definitive detection of the 
low amplitude DA hang-up.  DA levels remain elevated for at least 8 seconds following the end of MFB 
stimulation.  In both the Type 1 and slow domain, DA assumes an elevated steady state level exhibiting a 
clear characteristic DA CV fingerprint.  This >8 second elevation far exceeds any contribution of DA 
adsorption/desorption to the CFE surface in both duration and concentration (Bath et al., 2000).  This 
indicates that the DA hang-up observed in all five kinetic domains is physiologically relevant.  An 
elevated DA tone could play a role in synaptic plasticity.  Synaptic plasticity can manifest as short or long 
term facilitation or short or long term depression and has been shown to play a role in a learning and 
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memory (Hamilton et al., 2010).  Neurochemically, fast and slow DA domains have been shown to 
exhibit differences in short term plasticity upon repeated MFB stimulation (Cragg, 2003, Montague et 
al., 2004, Kita et al., 2007, Moquin and Michael, 2009, Chadchankar and Yavich, 2011, Shu et al., 2013).   
4.4.5:  Rethinking the model of DA clearance 
This study has revealed the existence of multiple linear clearance rates dependant on anatomical 
location, concentration dependent linear clearance rates and a long term DA hang-up feature.  These 
findings are in direct contradiction of the current description of Michaelis-Menten governed DAT 
mediated uptake (Wightman et al., 1988a, Wu et al., 2001b).  In fact, the current Michaelis-Menten 
model of DA clearance is unable to model the DA hang-up feature of the evoked DA overflow response 
(Figure 4.7b).  This requires a reassessment of the current model of DA clearance.  Our newly proposed 
model of DA uptake is no more complicated than Michaelis-Menten uptake, having the same number of 
adjustable parameters.  The new model incorporates first order DA clearance (Sabeti et al., 2002) and is 
capable of making excellent fits to the descending portion of all five DA kinetic domains within the 
dorsal striatum, including the DA hang-up feature (Figure 4.7a).  The presence of overshoots in our data 
are indicative of continuing mass transport effects after the end of stimulus and so we have chosen to fit 
only the back portion of the evoked DA response curves to our new uptake model, in an effort to 
minimize interference of any mass transport effects with uptake.  At this time, we do not assert any 
specific mechanism for the U or S terms.  The insight of this work is that the data is unable to be fit by 
the existing Michaelis-Menten model and are easily fit by first order uptake coupled with a constant 
efflux term.   
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4.5:  CONCLUSIONS 
The DA terminal field in the dorsal striatum is composed of five discrete kinetic domains, including the 
slow domain and the four sub domains of the fast domain (Type 1-4).  Each exhibits a significantly 
different kinetic profile.  Due to the complicated nature of DA signaling, extreme care and attention 
must be paid during analysis.  DA levels are elevated at concentrations at or near the LOD of FSCV 
detection methods for at least 8 seconds following MFB stimulation.  Therefore, any mathematical 
adjustment could possibly remove a DAergic feature, thus making the use of PCA data manipulation of 
great concern.   Our selective detection of DA does not require a deconvolution algorithm nor PCA 
adjustment and allows for the unbiased analysis of evoked DA overflow kinetics.  From this we were 
able to identify the DA hang-up feature and suggest a new first order model of DA clearance that 
provides an excellent fit to all five kinetic domains. 
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5.0:  CONCLUSIONS 
  
 
 
This dissertation details numerous discoveries that have the potential to greatly impact the 
understanding of DA transmission.  Using in vivo fast scan cyclic voltammetry at carbon fiber 
microelectrodes, we first discovered that the effects of the competitive DAT inhibitor, nomifensine, are 
domain dependent (Taylor et al., 2012).  Moreover, the domain dependent effects of nomifensine led to 
the restricted diffusion model of DA transmission in the dorsal striatum.  This model suggests that DA 
transmission throughout the extracellular space does not occur through free radial diffusion, as was 
suggested by previous models (Cragg et al., 2001, Cragg and Rice, 2004).  Instead, DA is subjected to a 
highly efficient restriction mechanism that limits the distance of DA diffusion (Sykova and Nicholson, 
2008).  In this case, evoked DA overflow is considered to be a tightly controlled balance between 
vesicular release, DAT mediated uptake and restricted diffusion.  The effects of restricted DA diffusion 
are only observed after DAT mediated uptake is inhibited by nomifensine. 
 We went on to test the efficiency of restricted diffusion to control DA crosstalk between fast 
and slow domains.  We discovered that DA is unable to diffuse between fast and slow domains, even in 
the presence of nomifensine (where conditions for DA diffusion are optimal) (Taylor et al., 2013).  
Furthermore, we discovered that the restriction mechanisms allow for varying concentration gradients 
between fast and slow domains.  Fast domains produced larger evoked DA overflow responses during 
high frequency stimulations (60 Hz), whereas low frequency stimulation (30 and 45 Hz) elicit higher 
evoked DA overflow in slow domains.  This interconversion in concentration gradients confirms that the 
fast and slow domains are completely isolated from each other and that a standing concentration 
gradient between the two domains does not exist over all conditions.  This supports the finding that the 
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slow domain is caused by the presence of a 2 µM resting basal DA concentration (Borland and Michael, 
2004, Wang et al., 2010).  If DA were allowed to freely diffuse between the fast and slow domains, the 
domain dependent difference in basal DA concentration could not exist.   
 Our continued work led to the discovery of four significantly different sub domains of the fast 
domain.  All four sub domains respond identically through the first 500 ms of a 3 second, 60 Hz MFB 
stimulation, but exhibit varying extents of regulation when stimulation exceeds one second.  When 
considered along with the slow domain, this confirms the existence of five discrete DA domains in the 
dorsal striatum.  All five domains exhibit a DA hang-up following MFB stimulation.  This confirms that DA 
establishes a long lasting steady state elevation following release.  While the mechanism underlying this 
DA elevation is unknown, a first order DA clearance model adjusted with a constant efflux term provides 
a remarkably close fit to the data.  Further work must be done to characterize any possible physiological 
relevance to the constant efflux source.   
 This work has the potential to be highly influential to the understanding of DA transmission.  In 
fact, the major findings of this dissertation have already served as the intellectual base for numerous 
studies in our laboratory.  The restricted diffusion model of DA transmission has been incorporated into 
a novel mathematical model of evoked DA overflow responses (Walters et al. submitted).  This model is 
no more complicated than the existing model based on Equations 1.5 and 2.1 of this dissertation, but is 
able to provide high correlation fits to previously unexplained features of the data.  The restricted 
diffusion model was also used to describe the effects of nomifensine on the fast and slow DA domains in 
the Nucleus Accumbens core region of brain (Shu et al., submitted). 
 The discovery of the domain dependent effects of the competitive DAT inhibitor, nomifensine, 
could be of great significance to the understanding and possible treatment of ADHD.  Approximately 
11% of children ages 4-17 (6.4 million) in the United States are being diagnosed with ADHD (CDC 2011).  
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This manifests an enormous economical burden on not only the families involved, but also the nation as 
a whole.  ADHD is believed to be the result of increased DA signaling in the brain (Gonon, 2009).  The 
current treatment for ADHD is the competitive DAT inhibitor, methylphenidate (Ritalin) 
(Schlochtermeier et al., 2011).  This choice of treatment is paradoxical being that competitive DAT 
inhibitors are classically known in increase the resting DA concentration in the brain (Church et al., 
1987), which would subsequently cause additional postsynaptic receptor signaling, only adding to the 
problem.  The finding that the competitive DAT inhibitor, nomifensine, acts in a domain dependent 
manner may provide some meaningful insight to this issue.  If Ritalin is acting through a similar domain 
dependent effect, one might be able to pinpoint the DA domain responsible for the symptomatology of 
ADHD and more selectively suppress it. 
While the physiological relevance underlying the existence of the five kinetic domains and the 
DA hang-up are unknown, there are a few possibilities that merit further testing.  First being the 
multiple functionalities of the DA system.  As previously described, DA is involved in a myriad of 
neurological tasks, such as motor control, sexual arousal, reward, reinforcement and addiction (Horn et 
al., 1979, Hull et al., 1999, Brooks, 2001, Urban et al., 2012).  It would make sense that these unique 
physiological functionalities would require specific modes of DA signaling, possibly afforded by different 
DA domains.  Furthermore, it serves to reason that DA transmission would be tightly regulated in space 
via restricted diffusion.  One could imagine the negative ramifications that could arise from eliciting a 
motor response from DA released for the intended purpose of signaling reward or sexual arousal.  This 
hypothesis could be tested by monitoring DA signaling in each of the five domains in the behaving rat. 
 Schizophrenia is a devastating mental disorder with symptomatology including delusions and 
paranoia.  The existence of the DA hang-up could play a role in better understanding schizophrenia 
though the effects of synaptic plasticity or long term DA signaling.  DA signaling is known to occur on 
96 
 
multiple time scales (Schultz, 2007), most notably as the result of tonic and phasic firing rates (Grace, 
1991).  Tonic firing is described as a slow pacemaker neuron firing that maintains the basal DA 
concentration in the extracellular space.  Phasic firing consists of short bursts of high frequency action 
potentials that result in a transient DA elevation.  Tonic and phasic firing patterns have garnered interest 
since they were found to be relevant to the pathophysiology of schizophrenia.  Schizophrenia is believed 
to be characterized by decreased tonic signaling.  Decreased tonic signaling results in a lower baseline 
DA concentration.  This low basal DA tone leads to an up regulation of DA receptors and an increased 
amplitude of DA released during phasic firing.  This elevated phasic DA signaling is believed to be the 
cause of the positive symptoms associated with Schizophrenia (delusions) (Grace, 1991).  The newly 
discovered preference of the slow domain for low frequency stimulation (Taylor et al., 2013), along with 
the DA hang-up feature could play a significant role in baseline receptor saturation and subsequent 
phasic firing.  From this, I hypothesize that the slow domain is responsible for tonic firing.  Furthermore, 
because of that, I hypothesize that Schizophrenia is a disorder of the slow domain.  Testing this 
hypothesis would first require determining the currently unknown physiological or anatomical cause of 
the slow domain.   
 In closing, the discoveries detailed in this dissertation raise interesting questions and provide a 
new prospective for studying the brain.  Many of the well characterized DAergic phenomena must be 
reexamined taking into account the newly discovered DA domains as well as the domain dependent 
effects of DA targeting drugs.  In doing so, it will be possible to gain further insight into the complex 
regulation of the DA system in route to the discovery of the cause and novel treatment techniques for 
various neurological disorders.  
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